[go: up one dir, main page]

TW200521207A - Liquid crystal alignment agent and liquid crystal display element - Google Patents

Liquid crystal alignment agent and liquid crystal display element Download PDF

Info

Publication number
TW200521207A
TW200521207A TW093130811A TW93130811A TW200521207A TW 200521207 A TW200521207 A TW 200521207A TW 093130811 A TW093130811 A TW 093130811A TW 93130811 A TW93130811 A TW 93130811A TW 200521207 A TW200521207 A TW 200521207A
Authority
TW
Taiwan
Prior art keywords
liquid crystal
phenoxy
crystal alignment
furan
dione
Prior art date
Application number
TW093130811A
Other languages
Chinese (zh)
Other versions
TWI346690B (en
Inventor
Shouichi Nakata
Atsushi Kumano
Original Assignee
Jsr Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jsr Corp filed Critical Jsr Corp
Publication of TW200521207A publication Critical patent/TW200521207A/en
Application granted granted Critical
Publication of TWI346690B publication Critical patent/TWI346690B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/52Liquid crystal materials characterised by components which are not liquid crystals, e.g. additives with special physical aspect: solvents, solid particles
    • C09K19/54Additives having no specific mesophase characterised by their chemical composition
    • C09K19/56Aligning agents
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/06Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
    • C08G73/10Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L79/00Compositions of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing nitrogen with or without oxygen or carbon only, not provided for in groups C08L61/00 - C08L77/00
    • C08L79/04Polycondensates having nitrogen-containing heterocyclic rings in the main chain; Polyhydrazides; Polyamide acids or similar polyimide precursors
    • C08L79/08Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
    • GPHYSICS
    • G02OPTICS
    • G02FOPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells
    • G02F1/133Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
    • G02F1/1333Constructional arrangements; Manufacturing methods
    • G02F1/1335Structural association of cells with optical devices, e.g. polarisers or reflectors
    • GPHYSICS
    • G02OPTICS
    • G02FOPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells
    • G02F1/133Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
    • G02F1/1333Constructional arrangements; Manufacturing methods
    • G02F1/1337Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers
    • G02F1/133711Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers by organic films, e.g. polymeric films
    • G02F1/133723Polyimide, polyamide-imide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Nonlinear Science (AREA)
  • Organic Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Mathematical Physics (AREA)
  • General Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Liquid Crystal (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Liquid Crystal Substances (AREA)

Abstract

To provide a liquid crystal alignment agent suitable for vertical alignment type liquid crystal display elements and may form a liquid alignment film excellent in vertical alignment property of liquid crystal. A liquid crystal alignment agent comprises a polymer having on the side chains at least one structure selected from the group consisting of a structure represented by the following formula (I) and a structure represented by the following formula (II), wherein A1 and B1 independently of each other represents hydrogen atom, a halogen atom or a cyano group, but at least one of A1 and B1 is a halogen atom or a cyano group.

Description

200521207 九、發明說明: 【發明所屬之技術領域】 本發明係有關一種液晶配向劑及液晶顯示元件。更詳言 之’係有關一種具有適合於垂直配向型液晶顯示元件用途 之垂直配向性的液晶配向劑及具備由該物所得的液晶配向 膜之液晶顯示元件。 【先前技術】 目前,液晶顯示元件爲在設有透明導電膜之基板表面上 形成聚醯胺、聚醯亞胺等所成的液晶配向膜,作爲液晶顯 示元件用基板,且使兩張對向配置,於其縫隙內形成具有 正介電各向異性之向列型液晶層成爲三明治構造之晶胞, 使液晶分子長軸自一方基板朝向另一方基板連續90度扭 轉、即具有TN型(扭曲向列)液晶晶胞之TN型液晶顯示元 件,係爲已知。 對此而言,垂直配向型液晶顯示元件係爲使介電各向異 性爲負的液晶垂直配向,藉由施加電壓以使液晶分子傾倒 予以運作者,就視野角、對比等而言優異,近年來盛行硏 究開發。 此處,爲使液晶垂直配向時,必須使液晶配向膜爲疏水 性,因此,配向劑中必須含有多量疏水性成份(以下稱爲垂 直配向成份)。該垂直配向成份通常大多使用脂肪族、脂環 族、具有氟系官能基者。然而,使用該垂直配向成份時, 會有垂直配向之安定性不充分的問題。 因此,企求開發垂直配向安定性優異的液晶配向劑。 【發明內容】 200521207 · 本發明之目的係提供一種垂直配向安定性優異的垂直 配向型液晶配向劑。 本發明之另一目的係提供一種具備由本發明液晶配向 劑所得液晶配向膜之液晶顯示元件。 本發明之其他目的及優點由下述說明可知。 本發明之上述目的及優點,第1係藉由一種液晶配向 劑,其特徵爲含有在側鏈上至少具有一種選自以下述式(I) 所示構造及下述式(II)所示構造之聚合物予以達成。 【化1】200521207 IX. Description of the invention: [Technical field to which the invention belongs] The present invention relates to a liquid crystal alignment agent and a liquid crystal display element. More specifically, '' relates to a liquid crystal alignment agent having a vertical alignment property suitable for a vertical alignment type liquid crystal display device application, and a liquid crystal display device including a liquid crystal alignment film obtained from the liquid crystal alignment agent. [Prior art] At present, a liquid crystal display element is a liquid crystal alignment film formed of polyimide, polyimide, or the like on a substrate surface provided with a transparent conductive film. As a substrate for a liquid crystal display element, two sheets are opposed to each other. It is arranged in the gap to form a nematic liquid crystal layer with positive dielectric anisotropy to form a sandwich cell. The long axis of the liquid crystal molecules is twisted 90 degrees continuously from one substrate to the other substrate. TN type liquid crystal display elements of nematic) liquid crystal cells are known. In this regard, the vertical alignment type liquid crystal display element is a liquid crystal vertical alignment with negative dielectric anisotropy, and it is operated by applying a voltage to cause the liquid crystal molecules to dump, which is excellent in terms of viewing angle and contrast. Come prevalent research development. Here, in order to align the liquid crystal vertically, the liquid crystal alignment film must be made hydrophobic. Therefore, the alignment agent must contain a large amount of a hydrophobic component (hereinafter referred to as a vertical alignment component). The vertical alignment component is usually an aliphatic, alicyclic, or fluorine-containing functional group. However, when using this vertical alignment component, there is a problem that the stability of the vertical alignment is insufficient. Therefore, development of a liquid crystal alignment agent excellent in vertical alignment stability is required. [Summary of the Invention] 200521207 · The object of the present invention is to provide a vertical alignment type liquid crystal alignment agent with excellent vertical alignment stability. Another object of the present invention is to provide a liquid crystal display element including a liquid crystal alignment film obtained from the liquid crystal alignment agent of the present invention. Other objects and advantages of the present invention will be apparent from the following description. The above-mentioned object and advantages of the present invention are based on a liquid crystal alignment agent of the first system, which is characterized in that it contains at least one selected from a structure represented by the following formula (I) and a structure represented by the following formula (II) in a side chain. Polymer. [Chemical 1]

(其中’A1及B1互相獨立地爲氫原子、鹵素原子或氰基, 惟V及B1中至少一個爲鹵素原子或氰基) 【化2】(Wherein 'A1 and B1 are independently a hydrogen atom, a halogen atom, or a cyano group, but at least one of V and B1 is a halogen atom or a cyano group] [Chemical 2]

N-N 本發明之上述目的及優點,第2係藉由具備由本發明液 晶配向劑所形成的液晶配向膜所成予以達成。 【發明效果】 藉由本發明,可提供適合作爲液晶配向膜時可形成液晶 垂直配向性良好的液晶配向膜之垂直配向型液晶顯示元件 200521207 的液晶配向劑。 【爲實施發明之最佳形態】 於下述中詳細說明本發明。 本發明之液晶配向劑含有在側鏈(以下稱爲「特定側鏈」) 具上述式(I)所示構造、或上述式(II)所示構造之聚合物。上 述式(I)中,A1及B1互相獨立地爲氫原子、鹵素原子或氰 基。其中,A1及B1中至少一個爲鹵素原子或氰基。該鹵素 原子具體例如氟原子、氯原子、溴原子及碘原子。其中以 氟原子較佳。 上述特定側鏈具體例如下述式(III)所示構造之基。 【化3】 ,P-Q-R1—R2 (⑴) 其中,P爲單鍵、-〇-、-c〇〇·或-C〇NH-,Q爲上述式(I) 所示構造或上述式(II)所示構造。而且,上述式(III)中R1 係爲2價脂環族基。2價脂環族基之脂環的具體例如環丙 烷環、環丁烷環、環戊烷環、環己烷環、環庚烷環、二環 己基環、多環己基環、及此等環中所含的1個或2個以上 氫原子可藉由烷基、芳基、烷氧基、芳氧基等1價有機基、 或鹵素原子取代的環。此外,上述式(III)中R2係表示碳數 爲1〜22之直鏈狀烷基,較佳者爲碳數2〜18之直鏈狀烷 基,更佳者爲碳數3〜10之直鏈狀烷基。 該具有特定側鏈之聚合物的架構構造,沒有特別的限 制,就耐熱性及電氣特性優異而言以聚醯胺酸、及使聚醯 胺酸脫水閉環所得的醯亞胺化聚合物較佳。 上述聚醯胺酸可藉由使下述式(IV)所示二胺(a)與下述式 200521207 (V)所示酸酐(b)聚縮合製得。而且,上述醯亞胺化聚合物可 藉由使上述聚醯胺酸脫水閉環製得。本發明液晶配向劑所 使用的具有特定側鏈之聚醯胺酸及醯亞胺化聚合物之合 成,係使用U)二胺與(b)酸酐中至少一方具有特定側鏈之化 合物。N-N The second object and advantages of the present invention are achieved by a liquid crystal alignment film comprising a liquid crystal alignment agent of the present invention. [Effects of the Invention] According to the present invention, a liquid crystal alignment agent 200521207 for a vertical alignment type liquid crystal display element 200521207 which is suitable for forming a liquid crystal alignment film with good vertical alignment when used as a liquid crystal alignment film can be provided. [Best Mode for Carrying Out the Invention] The present invention will be described in detail below. The liquid crystal alignment agent of the present invention contains a polymer having a structure represented by the formula (I) or a structure represented by the formula (II) in a side chain (hereinafter referred to as a "specific side chain"). In the above formula (I), A1 and B1 are each independently a hydrogen atom, a halogen atom or a cyano group. Among them, at least one of A1 and B1 is a halogen atom or a cyano group. Specific examples of the halogen atom include a fluorine atom, a chlorine atom, a bromine atom, and an iodine atom. Among them, a fluorine atom is preferred. Specific examples of the specific side chain include a base having a structure represented by the following formula (III). [Chemical formula 3], PQ-R1-R2 (i) wherein P is a single bond, -〇-, -c〇 ··, or -CONH-, and Q is a structure represented by the above formula (I) or the above formula ( II) Construction shown. In addition, in the formula (III), R1 is a divalent alicyclic group. Specific examples of the alicyclic ring of the divalent alicyclic group include a cyclopropane ring, a cyclobutane ring, a cyclopentane ring, a cyclohexane ring, a cycloheptane ring, a dicyclohexyl ring, a polycyclohexyl ring, and these rings One or two or more hydrogen atoms contained in the ring may be a ring substituted with a monovalent organic group such as an alkyl group, an aryl group, an alkoxy group, or an aryloxy group, or a halogen atom. In addition, in the formula (III), R2 represents a linear alkyl group having 1 to 22 carbon atoms, preferably a linear alkyl group having 2 to 18 carbon atoms, and more preferably 3 to 10 carbon atoms. Linear alkyl. The structure of the polymer having a specific side chain is not particularly limited, and polyimide and a polyimide obtained by dehydrating and closing the polyamidic acid are preferable in terms of excellent heat resistance and electrical characteristics. . The polyamidic acid can be obtained by polycondensing a diamine (a) represented by the following formula (IV) and an acid anhydride (b) represented by the following formula 200521207 (V). Further, the fluorene imidized polymer can be obtained by dehydrating and closing the polyfluorinated acid. The synthesis of the polyfluorinated acid having a specific side chain and the fluorinated imidized polymer used in the liquid crystal alignment agent of the present invention is a compound having a specific side chain in at least one of U) diamine and (b) anhydride.

(其中,Z2表示4價有機基) 上述具有特定側鏈二胺或酸野之使用比例,對使用的全 部二胺(a)及全部酸酐(b)合計而言以使用1〜1〇〇莫耳%較 佳,更佳者爲5〜5 0莫耳%。 <二胺〉 上述具有特疋側鍵之一胺’具體例如1-(2,3 -二氣- 4- (4-n-丙基環己基)本氧基)-2,4 - 一胺基苯、1-(2,3 -二氣/ - 4- (4-π -丁 基環己基)苯氧基)-2,4 -二胺基苯、ΐ-(2,3 -二氟- 4- (4·η -戊基 己基)本氧基)-2,4 - 一胺基苯、1-(2,3 -二氯- 4- (4-n -己基環 己基)苯氧基)-2,4 -二胺基苯、1-(2,3 -二_-4-(4-n -庚基環己 基)苯氧基)-2,4 -二胺基苯; 200521207 1-(2,3-二氰基-4-(4-η-丙基環己基)苯氧基)-2,4-二胺基 苯、1-(2,3-二氰基-4-(4-n-丁基環己基)苯氧基)-2,4-二胺基 苯、1-(2,3 - —•氯基- 4- (4-n -戊基環己基)苯氧基)-2,4 -—胺基 苯、1-(2,3-二氰基·4-(4-η-己基環己基)苯氧基)-2,4-二胺基 苯、1-(2,3-二氰基-4-(4-η-庚基環己基)苯氧基)-2,4-二胺基 苯; (2,3-二氟-4-(4-11-丙基環己基)苯基)-3,5-二胺基苯甲酸 酯、(2,3-二氟-4-(4-η-丁基環己基)苯基)-3,5-二胺基苯甲酸 醋、(2,3 -二氟- 4- (4-η -戊基環己基)苯基)-3,5 -二胺基苯甲酸 酯、(2,3-二氟-4·(4-η-己基環己基)苯基)-3,5-二胺基苯甲酸 酯、(2,3-二氟-4-(4-η-庚基環己基)苯基)-3,5-二胺基苯甲酸 酯; (2,3-二氰基-4-(4-η-丙基環己基)苯基)-3,5-二胺基苯甲酸 酯、(2,3·二氰基-4-(4-η-丁基環己基)苯基)-3,5-二胺基苯甲 酸酯、(2,3-二氰基-4-(4-η-戊基環己基)苯基)-3,5-二胺基苯 甲酸酯、(2,3-二氰基-4-(4-n-己基環己基)苯基)-3,5-二胺基 苯甲酸酯、(2,3-二氰基-4-(4-n-庚基環己基)苯基)-3,5-二胺 基苯曱酸酯; l-(6-(4-n-丙基環己基)-3-噠哄氧基)-2,4-二胺基苯、 l-(6-(4-n-丁基環己基)·3-噠阱氧基)-2,4-二胺基苯、 1-(6-(4-η-戊基環己基)·3-噠阱氧基)-2,4-二胺基苯、1-(6-(4-己基環己基)-3-噠畊氧基)-2,4-二胺基苯、l-(6-(4-n-庚基環 己基)-3-噠阱氧基)-2,4-二胺基苯; (6_(4-n-丙基環己基)-3-噠阱基)-3,5-二胺基苯甲酸酯、 (^㈠-心丁基環己基卜^噠哄基卜夂纟-二胺基苯甲酸酯、 -10- 200521207 (6-(4-n-戊基環己基)-3-噠阱基)-3,5-二胺基苯曱酸酯、 (6-(4-η-己基環己基)-3-噠畊基)-3, 5-二胺基苯甲酸酯、 (6-(4-n-庚基環己基)-3-噠畊基)-3,5-二胺基苯甲酸酯; 1-(2-氟-4-(4-n-丙基環己基)苯氧基)-2,4-二胺基苯、1-(2-氟-4-(4-n-丁基環己基)苯氧基)-2,4-二胺基苯、1-(2-氟 -4-(4-n-戊基環己基)苯氧基)-2,4-二胺基苯、1-(2·氟- 4-(4-n-己基環己基)苯氧基)·2,4-二胺基苯、1-(2-氟-4·(4-η-庚基環 己基)苯氧基)-2,4-二胺基苯; 1-(3-氟-4-(4-η-丙基環己基)苯氧基)-2,4·二胺基苯、1-(3-氟_4-(4-n-丁基環己基)苯氧基)-2,4-二胺基苯1-(3-氟 -4-(4-η-戊基環己基)苯氧基)-2,4-二胺基苯1-(3-氟- 4-(4-η· 己基環己基)苯氧基)-2,4-二胺基苯1-(3-氟-4-(4-η-庚基環 己基)苯氧基)-2,4-二胺基苯; 1-(2-氰基-4-(4-11-丙基環己基)苯氧基)-2,4-二胺基苯、 1-(2-氰基-4-(4·η-丁基環己基)苯氧基)-2,4-二胺基苯、1-(2-氰基_4·(4-η-戊基環己基)苯氧基)-2,4-二胺基苯、1-(2-氰基 -4-(4-n-己基環己基)苯氧基)-2,4-二胺基苯、1-(2-氰基 -4-(4-n-庚基環己基)苯氧基)-2,4-二胺基苯; 1-(3-氰基-4-(4-η·丙基環己基)苯氧基)-2,4-二胺基苯、 1-(3-氰基-4-(4-η-丁基環己基)苯氧基)-2,4-二胺基苯、1-(3-氰基-4·(4-η-戊基環己基)苯氧基)-2,4-二胺基苯、1-(3-氰基 -4-(4-n-己基環己基)苯氧基)-2,4-二胺基苯、1-(3-氰基 -4_(4-n-庚基環己基)苯氧基)-2,4-二胺基苯; (2·氟- 4-(4-n-丙基環己基)苯基)-3,5-二胺基苯甲酸酯、(2-氟-4-(4-n-丁基環己基)苯基)-3,5-二胺基苯甲酸酯、(2-氟 -11 - 200521207 -4-(4-n-戊基環己基)苯基)-3,5·二胺基苯甲酸酯、(2-氟 -4-(4-η-己基環己基)苯基)-3,5-二胺基苯甲酸酯、(2-氟 -4-(4-η-庚基環己基)苯基)-3,5-二胺基苯甲酸酯; (3 -氟-4-(4-η·丙基環己基)苯基)-3,5·二胺基苯甲酸酯、(3-氟_4-(4-η-丁基環己基)苯基)-3,5-二胺基苯甲酸酯、(3-氟 -4-(4-η-戊基環己基)苯基)-3,5-二胺基苯甲酸酯、(3-氟 -4·(4-η-己基環己基)苯基)-3,5-二胺基苯甲酸酯、(3-氟 _4-(4-η-庚基環己基)苯基)·3,5-二胺基苯曱酸酯; (2-氰基-4· (4-η-丙基環己基)苯基)-3,5-二胺基苯甲酸 酯、(2-氰基-4-(4-n-丁基環己基)苯基)-3,5-二胺基苯甲酸 酯、(2-氰基-4-(4-n-戊基環己基)苯基)-3,5-二胺基苯甲酸 酯、(2-氰基-4-(4-n-己基環己基)苯基)-3,5-二胺基苯甲酸 酯、(2-氰基-4-(4-n-庚基環己基)苯基)·3,5-二胺基苯甲酸 酯; (3-氰基- 4-(4-η-丙基環己基)苯基)-3,5-二胺基苯甲酸 酯、(3-氰基-4·(4-η-丁基環己基)苯基)-3,5-二胺基苯甲酸 酯、(3-氰基-4·(4-η-戊基環己基)苯基)-3,5-二胺基苯甲酸 酯、(3-氰基-4-(4-n-己基環己基)苯基)-3,5-二胺基苯甲酸 酯、(3-氰基-4-(4-n-庚基環己基)苯基)-3,5-二胺基苯甲酸 酯。於此等之中,以1-(2,3-二氟-4-(4-η·丙基環己基)苯氧 基)-2,4-二胺基苯、ΐ-(2,3-二氟-4-(4-η-丁基環己基)苯氧 基)-2,4-二胺基苯、ΐ-(2,3-二氟-4-(4-η-戊基環己基)苯氧 基)-2,4·二胺基苯、ΐ-(2,3-二氟-4-(4-η-己基環己基)苯氧 基)-2,4-二胺基苯、ΐ-(2,3-二氟-4-(4-η-庚基環己基)苯氧 基)-2,4-二胺基苯; -12- 200521207 1-(2,3-二氰基- 4-(4-n-丙基環己基)苯氧基)-2,4-二胺 苯、1-(2,3-二氰基-4-(4-n-丁基環己基)苯氧基)-2,4-二 苯、1-(2,3-二氰基-4-(4-n-戊基環己基)苯氧基)-2,4-二 苯、1-(2,3-二氰基-4-(4-n-己基環己基)苯氧基)-2,4-二 苯、1-(2,3-二氰基-4-(4-n_庚基環己基)苯氧基)-2,4-二 苯; (2,3-二氟- 4-(4-n-丙基環己基)苯基)-3,5-二胺基苯甲 酯、(2,3-二氟-4-(4-n-丁基環己基)苯基)-3,5-二胺基苯 酯、(2,3-二氟-4-(4-n-戊基環己基)苯基)-3,5-二胺基苯 酯、(2,3-二氟-4-(4-n-己基環己基)苯基)-3,5-二胺基苯 酯、(2,3-二氟-4-(4-n-庚基環己基)苯基)-3,5-二胺基苯 酯; (2,3-二氰基- 4-(4-n-丙基環己基)苯基)-3,5-二胺基苯 酯、(2,3-二氰基-4-(4-11-丁基環己基)苯基)-3,5-二胺基 酸酯、(2,3-二氰基-4-(4-11-戊基環己基)苯基)-3,5-二胺 甲酸酯、(2,3-二氰基-4-(4-n-己基環己基)苯基)-3,5-二 苯甲酸酯、(2,3-二氰基-4-(4-n-庚基環己基)苯基)-3,5-基苯甲酸酯; 丙基環己基)-3-噠阱氧基)-2,4-二胺基苯、 l-(6-(4-n-丁基環己基)-3 -喔哄氧基)-2,4 - 一胺基苯、 1-(6·(4-η-戊基環己基)-3-噠哄氧基)-2,4-二胺基苯、 l-(6-(4-n-己基環己基)-3-噠阱氧基)-2,4-二胺基苯、 l-(6-(4-n-庚基環己基)-3-噠阱氧基)-2,4-二胺基苯; (6_ (4-n-丙基環己基)-3-噠哄基)-3,5-二胺基苯甲酸酯 (6-(4-n-丁基環己基)-3-噠哄基)-3,5-二胺基苯甲酸酯、 基 胺基 胺基 胺基 胺基 酸 甲酸 甲酸 甲酸 甲酸 甲酸 苯甲 基苯 胺基 二胺 -13- 200521207 (6-(4-n -戊基環己基)-噠阱基)-3,5 -二胺基苯甲酸酯、 (6-(4-η·己基環己基噠哄基)-3,5-二胺基苯甲酸酯、 (6-(心η-庚基環己基)-3_噠畊基)-3,5-二胺基苯甲酸酯較佳。 本發明液晶配向劑中所含的聚合物合成時所使用的其他 二胺’例如卜苯二胺、^苯二胺、4,4、二胺基二苯基甲烷、 二胺基二苯基乙烷、4,4,_二胺基二苯基硫醚、4,4、二 胺基二苯基酞、3,3,_二甲基_4,4,_二胺基聯苯、4,4,_二胺基 N-苯甲醯苯胺、4,4、二胺基二苯醚、丨,弘二胺基萘、2,2,· 二甲基-4,4、二胺基聯苯、胺基-卜(4、胺基苯基)-1,3,3-三 甲基節滿、6-胺基·ΐ-(4,-胺基苯基)-1,3,3-三甲基茚滿、3,4,-二胺基二苯醚、3,3、二胺基二苯甲酮、3,4、二胺基二苯甲 酮、4,4’-二胺基二苯甲酮、2,2_雙[4_(4-胺基苯氧基)苯基] 丙院、2,2-雙[4-(4-胺基苯氧基)苯基]六氟丙烷、2,2-雙(4-月女基本基)六氟两院、2,2 -雙[4-(4 -胺基苯氧基)苯基]酿、ι,4-雙(4-胺基苯氧基)苯、心胺基苯氧基)苯、丨^雙门-胺基苯氧基)苯、9,9-雙(4-胺基苯基)-10-氫蒽、2,7-二胺基 燕、9,9-雙(4-胺基苯基)蕗、4,4,-伸甲基-雙(2-氯化苯胺)、 2,2’,5,5’-四氯_4,4’-二胺基聯苯、2,2’-二氯-4,4,-二胺基 -5,5’-一甲氧基聯苯、3,3’-二甲氧基-4,4、二胺基聯苯、 -亞苯基異亞丙基)雙苯胺、4,4,“m_亞苯基異亞丙 基)雙苯胺、2,2,-雙[4-(4-胺基-2-三氟化甲基苯氧基)苯基] 六赢丙烷、4,4,-二胺基-2,2,-雙(三氟化甲基)聯苯、4,4,-雙 [(4-胺基-2-三氟化甲基)苯氧基]-八氟化聯苯等之芳香族二 胺; 間苯二甲基二胺、丨,3 -丙烷二胺、四甲二胺、五甲二胺、 -14- 200521207 六甲二胺、七甲二胺、八甲二胺、九甲二胺、4,4 -二胺基七 甲二胺、1,4 -二胺基環己院、異佛爾酮二胺、四氫二環戊二 烯二胺、六氫-4,7-甲醇茚滿二甲二胺、三環[6.2.1.02·7]-十 一烯二甲基二胺、4,4’-伸甲基雙(環己胺)等之脂肪族及脂 環式二胺; 2,3 -二胺基卩比卩定、2,6 -二胺基批卩定、3,4 - 一胺基卩比Π定、2,4 -二胺基嗤D定、5,6 ·二胺基-2,3 -二氰基卩比畊、5,6 -二胺基-2,4 -二羥基嘧啶、2,4-二胺基-6-二甲基胺基-1,3,5-三畊、1,4-雙 (3 -胺基丙基)哌阱、二胺基-6-異丙氧基- I,3,5 -三哄、2,4-二胺基-6-甲氧基-I,3,5·三阱、2,心二胺基·6_苯基-1,3,5_三 阱、2,4-二胺基-6-甲基-s-三阱、2,4-二胺基-1,3,5-三阱、4,6-二胺基-2-乙烯基-s-三哄、2,4 -二胺基-5 -苯基嗤’ 2,6 -二胺 基嘌tj令、5,6-二胺基-二甲基尿喃π定、二胺基 三唑、6,9-二胺基-2-乙氧基 啶乳酸酯、3,8-二胺基-6_苯基 菲啶、1,4-二胺基哌阱’ 3,6_二胺基啶、雙(4-胺基苯基) 苯胺及下述式(VI)〜(VII)所示化合物等之在分子內具有2 個一'級胺基及該一級胺基以外之氮原子的二胺; 【化6】(Wherein Z2 represents a tetravalent organic group) The above-mentioned usage ratio of the specific side chain diamine or acid field is 1 to 100 moles for all the diamines (a) and all acid anhydrides (b) used in total. The ear% is better, more preferably 5 to 50 mole%. < Diamine> A specific example of the above-mentioned amine having one of the side bonds is, for example, 1- (2,3-digas-4- (4-n-propylcyclohexyl) benzyloxy) -2,4-monoamine Phenylbenzene, 1- (2,3-digas /-4- (4-π-butylcyclohexyl) phenoxy) -2,4-diaminobenzene, fluorene- (2,3-difluoro- 4- (4 · η -pentylhexyl) benzyloxy) -2,4 -monoaminobenzene, 1- (2,3-dichloro-4 (4-n-hexylcyclohexyl) phenoxy) -2,4-diaminobenzene, 1- (2,3-di_-4- (4-n-heptylcyclohexyl) phenoxy) -2,4-diaminobenzene; 200521207 1- ( 2,3-dicyano-4- (4-η-propylcyclohexyl) phenoxy) -2,4-diaminobenzene, 1- (2,3-dicyano-4- (4- n-butylcyclohexyl) phenoxy) -2,4-diaminobenzene, 1- (2,3-— • chloro- 4- (4-n-pentylcyclohexyl) phenoxy)- 2,4--aminobenzene, 1- (2,3-dicyano · 4- (4-η-hexylcyclohexyl) phenoxy) -2,4-diaminobenzene, 1- (2, 3-dicyano-4- (4-η-heptylcyclohexyl) phenoxy) -2,4-diaminobenzene; (2,3-difluoro-4- (4-11-propyl ring Hexyl) phenyl) -3,5-diaminobenzoate, (2,3-difluoro-4- (4-η-butylcyclohexyl) phenyl) -3,5-diaminobenzene Formic acid , (2,3-difluoro-4 (4-η-pentylcyclohexyl) phenyl) -3,5-diaminobenzoate, (2,3-difluoro-4 · (4- η-hexylcyclohexyl) phenyl) -3,5-diaminobenzoate, (2,3-difluoro-4- (4-η-heptylcyclohexyl) phenyl) -3,5- Diaminobenzoate; (2,3-dicyano-4- (4-η-propylcyclohexyl) phenyl) -3,5-diaminobenzoate, (2,3 · Dicyano-4- (4-η-butylcyclohexyl) phenyl) -3,5-diaminobenzoate, (2,3-dicyano-4- (4-η-pentyl) Cyclohexyl) phenyl) -3,5-diaminobenzoate, (2,3-dicyano-4- (4-n-hexylcyclohexyl) phenyl) -3,5-diamino Benzoate, (2,3-dicyano-4- (4-n-heptylcyclohexyl) phenyl) -3,5-diaminophenylbenzoate; l- (6- (4- n-propylcyclohexyl) -3-pyridyloxy) -2,4-diaminobenzene, l- (6- (4-n-butylcyclohexyl) · 3-pyridyloxy) -2 1,4-diaminobenzene, 1- (6- (4-η-pentylcyclohexyl) · 3-pyridyloxy) -2,4-diaminobenzene, 1- (6- (4-hexyl Cyclohexyl) -3-pyridyloxy) -2,4-diaminobenzene, l- (6- (4-n-heptylcyclohexyl) -3-pyridyloxy) -2,4-di Aminobenzene; (6_ (4-n- Cyclohexyl) -3-pyridyl) -3,5-diaminobenzoate, (^ ㈠-cardiobutylcyclohexyl) ^^ yl-diaminobenzoate, -10- 200521207 (6- (4-n-pentylcyclohexyl) -3-pyridyl) -3,5-diaminophenylbenzoate, (6- (4-η-hexylcyclohexyl)- 3-pyridyl) -3,5-diaminobenzoate, (6- (4-n-heptylcyclohexyl) -3-pyridyl) -3,5-diaminobenzoic acid Esters; 1- (2-fluoro-4- (4-n-propylcyclohexyl) phenoxy) -2,4-diaminobenzene, 1- (2-fluoro-4- (4-n-butane Cyclohexyl) phenoxy) -2,4-diaminobenzene, 1- (2-fluoro-4- (4-n-pentylcyclohexyl) phenoxy) -2,4-diaminobenzene , 1- (2 · fluoro-4 (4-n-hexylcyclohexyl) phenoxy) · 2,4-diaminobenzene, 1- (2-fluoro-4 · (4-η-heptyl ring Hexyl) phenoxy) -2,4-diaminobenzene; 1- (3-fluoro-4- (4-η-propylcyclohexyl) phenoxy) -2,4 · diaminobenzene, 1 -(3-fluoro_4- (4-n-butylcyclohexyl) phenoxy) -2,4-diaminobenzene 1- (3-fluoro-4- (4-η-pentylcyclohexyl) Phenoxy) -2,4-diaminobenzene 1- (3-fluoro- 4- (4-η · hexylcyclohexyl) phenoxy) -2,4-diaminobenzene 1- (3-fluoro -4- (4-η-heptylcyclohexyl Phenoxy) -2,4-diaminobenzene; 1- (2-cyano-4- (4-11-propylcyclohexyl) phenoxy) -2,4-diaminobenzene, 1- (2-cyano-4- (4 · η-butylcyclohexyl) phenoxy) -2,4-diaminobenzene, 1- (2-cyano-4 · (4-η-pentyl ring Hexyl) phenoxy) -2,4-diaminobenzene, 1- (2-cyano-4- (4-n-hexylcyclohexyl) phenoxy) -2,4-diaminobenzene, 1 -(2-cyano-4- (4-n-heptylcyclohexyl) phenoxy) -2,4-diaminobenzene; 1- (3-cyano-4- (4-η · propyl) Cyclohexyl) phenoxy) -2,4-diaminobenzene, 1- (3-cyano-4- (4-η-butylcyclohexyl) phenoxy) -2,4-diaminobenzene 1- (3-cyano-4 · (4-η-pentylcyclohexyl) phenoxy) -2,4-diaminobenzene, 1- (3-cyano-4- (4-n- Hexylcyclohexyl) phenoxy) -2,4-diaminobenzene, 1- (3-cyano-4_ (4-n-heptylcyclohexyl) phenoxy) -2,4-diaminobenzene ; (2 · fluoro-4- (4-n-propylcyclohexyl) phenyl) -3,5-diaminobenzoate, (2-fluoro-4- (4-n-butylcyclohexyl) ) Phenyl) -3,5-diaminobenzoate, (2-fluoro-11-200521207 -4- (4-n-pentylcyclohexyl) phenyl) -3,5 · diaminobenzene Formate, (2-fluoro-4- (4-η-hexyl) Cyclohexyl) phenyl) -3,5-diaminobenzoate, (2-fluoro-4- (4-η-heptylcyclohexyl) phenyl) -3,5-diaminobenzoic acid Ester; (3-fluoro-4- (4-η · propylcyclohexyl) phenyl) -3,5 · diaminobenzoate, (3-fluoro-4- (4-η-butyl ring Hexyl) phenyl) -3,5-diaminobenzoate, (3-fluoro-4- (4-η-pentylcyclohexyl) phenyl) -3,5-diaminobenzoate (3-fluoro-4 · (4-η-hexylcyclohexyl) phenyl) -3,5-diaminobenzoate, (3-fluoro_4- (4-η-heptylcyclohexyl) Phenyl) · 3,5-diaminophenylbenzoate; (2-cyano-4 · (4-η-propylcyclohexyl) phenyl) -3,5-diaminobenzoate, (2-cyano-4- (4-n-butylcyclohexyl) phenyl) -3,5-diaminobenzoate, (2-cyano-4- (4-n-pentyl ring) Hexyl) phenyl) -3,5-diaminobenzoate, (2-cyano-4- (4-n-hexylcyclohexyl) phenyl) -3,5-diaminobenzoate (2-cyano-4- (4-n-heptylcyclohexyl) phenyl) · 3,5-diaminobenzoate; (3-cyano-4- (4-η-propyl) Cyclohexyl) phenyl) -3,5-diaminobenzoate, (3-cyano-4 · (4-η-butylcyclohexyl) benzene ) -3,5-diaminobenzoate, (3-cyano-4 · (4-η-pentylcyclohexyl) phenyl) -3,5-diaminobenzoate, (3 -Cyano-4- (4-n-hexylcyclohexyl) phenyl) -3,5-diaminobenzoate, (3-cyano-4- (4-n-heptylcyclohexyl) benzene Radical) -3,5-diaminobenzoate. Among these, 1- (2,3-difluoro-4- (4-η · propylcyclohexyl) phenoxy) -2,4-diaminobenzene, fluorene- (2,3- Difluoro-4- (4-η-butylcyclohexyl) phenoxy) -2,4-diaminobenzene, fluorene- (2,3-difluoro-4- (4-η-pentylcyclohexyl) ) Phenoxy) -2,4 · diaminobenzene, fluorene- (2,3-difluoro-4- (4-η-hexylcyclohexyl) phenoxy) -2,4-diaminobenzene, ΐ- (2,3-difluoro-4- (4-η-heptylcyclohexyl) phenoxy) -2,4-diaminobenzene; -12- 200521207 1- (2,3-dicyano -4- (4-n-propylcyclohexyl) phenoxy) -2,4-diaminebenzene, 1- (2,3-dicyano-4- (4-n-butylcyclohexyl) benzene (Oxy) -2,4-diphenyl, 1- (2,3-dicyano-4- (4-n-pentylcyclohexyl) phenoxy) -2,4-diphenyl, 1- (2 , 3-dicyano-4- (4-n-hexylcyclohexyl) phenoxy) -2,4-diphenyl, 1- (2,3-dicyano-4- (4-n-heptyl) Cyclohexyl) phenoxy) -2,4-diphenyl; (2,3-difluoro-4- (4-n-propylcyclohexyl) phenyl) -3,5-diaminobenzyl, (2,3-difluoro-4- (4-n-butylcyclohexyl) phenyl) -3,5-diaminophenyl ester, (2,3-difluoro-4- (4-n-pentyl) Cyclohexyl) phenyl) -3,5-diaminophenyl ester, (2,3-difluoro-4- (4-n- Cyclohexyl) phenyl) -3,5-diaminophenyl ester, (2,3-difluoro-4- (4-n-heptylcyclohexyl) phenyl) -3,5-diaminobenzene Ester; (2,3-dicyano-4- (4-n-propylcyclohexyl) phenyl) -3,5-diaminophenyl ester, (2,3-dicyano-4- (4 -11-butylcyclohexyl) phenyl) -3,5-diamino ester, (2,3-dicyano-4- (4-11-pentylcyclohexyl) phenyl) -3,5 -Dicarbamate, (2,3-dicyano-4- (4-n-hexylcyclohexyl) phenyl) -3,5-dibenzoate, (2,3-dicyano- 4- (4-n-heptylcyclohexyl) phenyl) -3,5-ylbenzoate; propylcyclohexyl) -3-pyridyloxy) -2,4-diaminobenzene, l -(6- (4-n-butylcyclohexyl) -3 -ohexyloxy) -2,4-monoaminobenzene, 1- (6 · (4-η-pentylcyclohexyl) -3- Pyridoxy) -2,4-diaminobenzene, l- (6- (4-n-hexylcyclohexyl) -3-pyridyloxy) -2,4-diaminobenzene, l- ( 6- (4-n-heptylcyclohexyl) -3-pyridyloxy) -2,4-diaminobenzene; (6- (4-n-propylcyclohexyl) -3-pyridyl)- 3,5-diaminobenzoate (6- (4-n-butylcyclohexyl) -3-pyridyl) -3,5-diaminobenzoate, aminoaminoamine Amino Acid formic acid formic acid formic acid formic acid benzylaniline diamine-13- 200521207 (6- (4-n-pentylcyclohexyl) -pyridyl) -3,5-diaminobenzoate, (6 -(4-η · hexylcyclohexylpyridyl) -3,5-diaminobenzoate, (6- (heart η-heptylcyclohexyl) -3_pyridyl) -3,5- Diaminobenzoates are preferred. Other diamines used in the synthesis of the polymer contained in the liquid crystal alignment agent of the present invention, such as phenylenediamine, phenylenediamine, 4,4, diaminodiphenylmethane, diaminodiphenylethyl Alkane, 4,4, _diaminodiphenyl sulfide, 4,4, diaminodiphenylphthalide, 3,3, _dimethyl_4,4, _diaminobiphenyl, 4, 4, _diamino N-benzidine aniline, 4,4, diamino diphenyl ether, 丨 diamino naphthalene, 2, 2, dimethyl-4, 4, diamino biphenyl, Amino-Bu (4, aminophenyl) -1,3,3-trimethylbenzyl, 6-amino · fluorene- (4, -aminophenyl) -1,3,3-trimethyl Indan, 3,4, -diaminodiphenyl ether, 3,3, diaminobenzophenone, 3,4, diaminobenzophenone, 4,4'-diaminodiphenyl Methyl ketone, 2,2_bis [4- (4-aminophenoxy) phenyl] propane, 2,2-bis [4- (4-aminophenoxy) phenyl] hexafluoropropane, 2 , 2-Bis (4-monthly female basic group) hexafluoromethane, 2,2-bis [4- (4-aminophenoxy) phenyl], ι, 4-bis (4-aminobenzene (Oxy) benzene, cardioaminophenoxy) benzene, ^ bis-amino-aminophenoxy) benzene, 9,9-bis (4-aminophenyl) -10-hydroanthracene, 2,7- Diamine Swallow, 9,9-bis (4-aminophenyl) fluorene, 4,4, -methylene-bis (2-chloroaniline), 2,2 ', 5,5'-tetrachloro-4, 4'-diaminobiphenyl, 2,2'-dichloro-4,4, -diamino-5,5'-monomethoxybiphenyl, 3,3'-dimethoxy-4, 4. Diamine biphenyl, -phenylene isopropylidene) bisaniline, 4,4, "m_phenylene isopropylidene) bisaniline, 2,2, -bis [4- (4- Amino-2-trifluoromethylphenoxy) phenyl] Hexapropane, 4,4, -diamino-2,2, -bis (trifluoromethyl) biphenyl, 4,4, -Bis [(4-amino-2-trifluoromethyl) phenoxy] -aromatic diamines such as biphenyl octafluoride; m-xylylenediamine, 丨, 3-propanediamine, Tetramethyldiamine, Pentamethyldiamine, -14-200521207 Hexamethyldiamine, Heptamethyldiamine, Octadiamine, Ninemethyldiamine, 4,4-Diamino Heptamethyldiamine, 1,4-Diamine Aminocyclohexane, isophoronediamine, tetrahydrodicyclopentadienediamine, hexahydro-4,7-methanolindanedimethyldiamine, tricyclo [6.2.1.02 · 7] -eleven Aliphatic and alicyclic diamines such as dimethylene diamine, 4,4'-methylenebis (cyclohexylamine), etc .; , 2,6-diaminopyridine, 3,4-monoaminopyridine, 2,4-diaminopyridine, 5,6-diamino-2,3-dicyano卩 Bigen, 5,6-diamino-2,4-dihydroxypyrimidine, 2,4-diamino-6-dimethylamino-1,3,5-trigon, 1,4-bis (3-Aminopropyl) piperidine, diamino-6-isopropoxy-I, 3,5-triazine, 2,4-diamino-6-methoxy-I, 3,5 · Triple well, 2, cardiodiamino group · 6-phenyl-1,3,5_ triple well, 2,4-diamino-6-methyl-s-triple, 2,4-diamine group -1,3,5-Tritrap, 4,6-diamino-2-vinyl-s-trioxine, 2,4-diamino-5 -phenylfluorene '2,6-diaminopurine tj, 5,6-diamino-dimethyluridine, diaminotriazole, 6,9-diamino-2-ethoxypyridine lactate, 3,8-diamine -6-phenylphenanthridine, 1,4-diaminopiperidin '3,6-diaminopyridine, bis (4-aminophenyl) aniline and the following formulae (VI) to (VII) Compounds such as diamines having two mono-amino groups and nitrogen atoms other than the primary amino group in the molecule;

(其中,R3爲具有選自於吡啶、嘧啶、三阱、哌啶及哌阱 之含氮原子的環構造之1價有機基,X1爲2價有機基) 【化7】 -15- 200521207 h2n(Wherein R3 is a monovalent organic group having a ring structure selected from pyridine, pyrimidine, triple well, piperidine, and piperidine, and X1 is a divalent organic group) [Chem. 7] -15- 200521207 h2n

17 / ί m (其中’ R4爲具有選自於吡啶、嘧啶、三阱、哌啶及哌哄 之含氮原子的環構造之2價有機基,X2爲2價有機基,數 個存在的X2可以相同或不同) 下述式(VIII)所是單取代苯二胺類;下述式(ΙΧ)所是二胺 基有機砂氧院;17 / ί m (wherein R4 is a divalent organic group having a ring structure selected from pyridine, pyrimidine, triple well, piperidine, and piperidine, X2 is a divalent organic group, and several X2 are present It may be the same or different.) The following formula (VIII) is a mono-substituted phenylenediamine; the following formula (IX) is a diamine-based organic sand oxygen institute;

(其中’ R5爲選自於- 〇-、·◦〇〇-、-〇c〇-、-NHCO-、-CONH- 及-C◦-之2價有機基’ R6爲具有選自於膽固醇架構、三氟 化甲基及氟基之1價有機基或碳數6〜3〇之烷基) 化9】 H2N-(CH2)p—Si R7 1 5卜 R7 - (CH2)p—NH2 J q 2之烴基 (IX) R7 •O—Si— R7 (其中,R7爲碳數1〜12之烴基,數個存在的r7可以相 同或不同,P爲1〜3之整數,q爲丨〜2〇之整數) 可例如下述式(1)〜(5)所示之化合物。此等之二胺化合物 可以單獨使用或2種以上組合使用。 【化1 〇】 -16- 200521207(Wherein 'R5 is a divalent organic group selected from -〇-, · ◦〇〇-, -〇c〇-, -NHCO-, -CONH-, and -C◦-' R6 has a structure selected from the group consisting of cholesterol , Trifluoromethyl and fluoro-based monovalent organic groups or alkyl groups having 6 to 30 carbon atoms) 9] H2N- (CH2) p—Si R7 1 5 R7-(CH2) p—NH2 J q Hydrocarbon group (IX) R7 • O—Si— R7 (where R7 is a hydrocarbon group having 1 to 12 carbon atoms, several existing r7 may be the same or different, P is an integer of 1 to 3, and q is 丨 to 2〇 (Integer): For example, compounds represented by the following formulae (1) to (5). These diamine compounds can be used alone or in combination of two or more. [Chemical 〇] -16- 200521207

(其中,y爲2〜12之整數,z爲1〜5之整數) 於此等之中,以P-苯二胺、4,4’-二胺基二苯基甲烷、4,4’-二胺基二苯基硫醚、1,5·二胺基萘、2,7-二胺基莠、4,4’-二 胺基二苯醚、2,2-雙[4-(4-胺基苯氧基)苯基]丙烷、9,9-雙(4-胺基苯基)荞、2,2-雙[4-(4-胺基苯氧基)苯基]六氟化丙烷、 2,2-雙(4-胺基苯基)六氟化丙烷、4,4’-(m-亞苯基二異亞丙 基)雙苯胺、1,4·環己烷二胺、4,4’-亞甲基雙(環己胺)、1,4-雙(4-胺基苯氧基)苯、4,4’-雙(4-胺基苯氧基)聯苯、上述式 (1)〜(5 )所示化合物、2,6 -二胺基吡啶、3,4 -二胺基吡啶、 2,4-二胺基吡啶、2,4-二胺基嘧啶、3,6-二胺基 啶、上述 -17- 200521207 式(VI)所示化合物中下述式(6)所示之化合物、上述式(VII) 所示化合物中下述式(7)所示之化合物及上述式(VIII)所示 化合物中下述式(8)〜(17)所示之化合物、及上述式(IX)所不 化合物中丨,3-雙(3-胺基丙基)六甲基二矽氧烷較佳。 【化1 1】(Where y is an integer of 2 to 12 and z is an integer of 1 to 5) Among these, P-phenylenediamine, 4,4'-diaminodiphenylmethane, 4,4'- Diaminodiphenyl sulfide, 1,5 · diaminonaphthalene, 2,7-diaminofluorene, 4,4'-diaminodiphenyl ether, 2,2-bis [4- (4- Aminophenoxy) phenyl] propane, 9,9-bis (4-aminophenyl) buckwheat, 2,2-bis [4- (4-aminophenoxy) phenyl] propane hexafluoride , 2,2-bis (4-aminophenyl) hexafluoropropane, 4,4 '-(m-phenylene diisopropylidene) bisaniline, 1,4 · cyclohexanediamine, 4 , 4'-methylenebis (cyclohexylamine), 1,4-bis (4-aminophenoxy) benzene, 4,4'-bis (4-aminophenoxy) biphenyl, the above formula (1) to (5) compounds, 2,6-diaminopyridine, 3,4-diaminopyridine, 2,4-diaminopyridine, 2,4-diaminopyrimidine, 3,6 -Diaminopyridine, the compound represented by the following formula (6) among the compounds represented by the above formula (VI), -17- 200521207, the compound represented by the following formula (7) among the compounds represented by the formula (VII), and Among the compounds represented by the formula (VIII), compounds represented by the following formulae (8) to (17), and the above (IX) are not compounds Shu, 3-bis (3-aminopropyl) siloxane silica hexamethyldisilazane preferred. 【Chemical 1 1】

-18- 200521207 <四羧酸二酐> 具有特定側鏈之四羧酸酐,具體例如l,3,3a,4,5,9b-六氫 -4-(2,3-二氟- 4-(4-n-丙基環己基)苯氧基)-5-(四氫-2,5-二羰 基-3-呋喃基)-萘并[l,2-c]-呋喃-1,3-二酮、l,3,3a,4,5,9b-A 氫-4-(2,3-二氟- 4-(4-n-丁基環己基)苯氧基)-5-(四氫-2,5-二 羰基-3-呋喃基)-萘并[l,2_c]-呋喃-1,3-二酮、l,3,3a,4,5,9b-六氫- 4-(2,3-二氟- 4-(4-n-戊基環己基)苯氧基)-5-(四氫-2,5-二羰基-3-呋喃基 >-萘并[l,2_c]-呋喃-1,3-二酮、 1,3,3a,4,5,9b-六氫-4-(2,3-二氟-4-(4-n-己基環己基)苯氧 基)-5-(四氫-2,5-二羰基-3-呋喃基)-萘并[l,2-c]-呋喃-1,3-二酮、l,3,3a,4,5,9b-六氫-4-(2,3-二氟-4-(4-n-己基環己基) 苯氧基)-5-(四氫-2,5-二羰基-3-呋喃基)-萘并[1,2-(:]-呋喃 -1,3-二酮、1,3,3&,4,5,91)-六氫-4-(2,3-二氟-4-(4-11-庚基環己 基)苯氧基)-5-(四氫-2,5-二羰基-3-呋喃基)-萘并[1,2-c]-呋 喃-1,3-二酮; l,3,3a,4,5,9b-六氫-4-(2,3-二氰基-4-(4-n-丙基環己基)苯 氧基)-5-(四氫-2,5-二羰基-3-呋喃基)-萘并[1,2-c]-呋喃 -1,3-二酮、1,3,3&,4,5,91)-六氫-4-(2,3-二氰基-4-(4-11-丁基環 己基)苯氧基)-5-(四氫- 2,5-二羰基-3_呋喃基)-萘并[l,2-c;l· 呋喃·l,3-二酮、l,3,3a,4,5,9b-六氫-4-(2,3-二氰基-4-(4-n_ 戊基環己基)苯氧基)-5-(四氫-2,5-二羰基-3-呋喃基)-萘并 [1,2-(:]-呋喃-1,3-二酮、1,3,3&,4,5,91)-六氫-4-(2,3-二氰基 _4-(4-n-己基環己基)苯氧基)-5-(四氫-2,5-二羰基-3-呋喃 基)-萘并[1,2-c]-呋喃-1,3-二酮、l,3,3a,4,5,9b-六氫-4-(2,3-二氰基- 4-(4·η-庚基環己基)苯氧基)-5-(四氫-2,5-二羰基-3- 200521207 呋喃基)-萘并[l,2-c] -呋喃-1,3 -二酮; l,3,3a,4,5,9b-六氫-4-(6-(4-n-丙基環己基)-3-噠哄氧 基)-5-(四氫-2,5-二羰基-3-呋喃基)-萘并[l,2-c]-呋喃-1,3-二酮、1,3,3^4,5,91六氫-4-(6-(4-11-丁基環己基)-3-噠哄氧 基)-5-(四氫·2,5-二羰基-3-呋喃基)-萘并[l,2·c]-呋喃-l,3-二酮、l,3,3a,4,5,9b-六氫-4-(6-(4-n-戊基環己基)-:3-噠阱氧 基)-5-(四氫-2,5-二羰基-3-呋喃基)-萘并[l,2-c]-呋喃-1,3-二酮、1,3,33,4,5,91)-六氫-4-(6-(4-11-己基環己基)-3-噠哄氧 基)-5-(四氫-2,5-二羰基-3-呋喃基)-萘并[1,2<]-呋喃-1,3- φ 二酮、1,3,38,4,5,913-六氫-4-(6-(4-11-庚基環己基)-3-噠畊氧 基)-5-(四氫-2,5-二羰基-3-呋喃基)-萘并[l,2-c]-呋喃-1,3-二酮; l,3,3a,4,5,9b-六氫-4-(2-氟-4-(4-n-丙基環己基)苯氧 基)-5-(四氫-2,5-二羰基-3-呋喃基)-萘并[l,2-c]-呋喃-1,3-二酮、1,3,3&,4,5,913-六氫-4-(2-氟-4-(4-11-丁基環己基)苯氧 基)-5-(四氫-2,5-二羰基-3-呋喃基)-萘并[l,2-c]-呋喃-1,3-二酮、l,3,3a,4,5,9b-六氫-4-(2-氟-4-(4-n-戊基環己基)苯氧 · 基)-5-(四氫- 2,5-二羰基-3·呋喃基)-萘并[l,2-c]-呋喃-l,3-二酮、l,3,3a,4,5,9b-六氫-4-(2-氟-4-(4-n-己基環己基)苯氧 基)-5-(四氫-2,5-二羰基-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮、1,3,3&,4,5,91^六氫-4-(2-氟-4-(4-11-庚基環己基)苯氧 基)-5-(四氫-2,5-二羰基-3-呋喃基)-萘并[l,2-c;l·呋喃-l,3-二酮; l,3,3a,4,5,9b-六氫-4-(3-氟-4-(4-η·丙基環己基)苯氧 基)-5-(四氫-2,5-二羰基-3-呋喃基)-萘并[1,2-〇]-呋喃-1,3- -20- 200521207 二酮、1,3,32,4,5,913-六氫-4-(3-氟-4-(4-11-丁基環己基)苯氧 基)-5-(四氫-2,5-二羰基-3-呋喃基)-萘并[l,2-c]-呋喃-1,3-二酮、l,3,3a,4,5,9b-六氫-4-(3-氟-4-(4-n-戊基環己基)苯氧 基)-5-(四氫-2,5-二羰基-3-呋喃基)-萘并[l,2-c]-呋喃-1,3-二酮、1,3,32,4,5,91)-六氫-4-(3-氟-4-(4-11-己基環己基)苯氧 基)-5-(四氫-2,5-二羰基-3-呋喃基)-萘并[l,2·c;l·呋喃-l,3-二酮、l,3,3a,4,5,9b-六氫-4-(3-氟-4-(4-n-庚基環己基)苯氧 基)-5-(四氫-2,5-二羰基-3-呋喃基)-萘并[l,2-c]-呋喃-1,3-二酮; 1,3,3a,4,5,9b-六氫-4-(2-氰基-4-(4-η-丙基環己基)苯氧 基)-5-(四氫-2,5-二羰基-3-呋喃基)-萘并[l,2-c^呋喃-l,3-二酮、l,3,3a,4,5,9b-六氫-4-(2-氰基-4-(4-n·丁基環己基)苯 氧基)-5-(四氫-2,5-二羰基-3·呋喃基)-萘并[l,2-c] -呋喃 -1,3-二酮、1,3,38,4,5,913-六氫-4-(2-氰基-4-(4-11-戊基環己基) 苯氧基)-5-(四氫- 2,5-二羰基-3-呋喃基)-萘并[l,2-c]-呋喃 -1,3-二酮、l,3,3a,4,5,9b-六氫- 4-(2-氰基- 4-(4-n-己基環己基) 苯氧基)-5-(四氫-2,5-二羰基-3-呋喃基)-萘并[1,2-〇]-呋喃 -1,3-二酮、1,3,3&,4,5,91)-六氫-4-(2-氰基-4-(4-11-庚基環己基) 苯氧基)-5-(四氫-2,5-二羰基-3-呋喃基)-萘并[l,2-c]-呋喃 -1,3·二酮; l,3,3a,4,5,9b-六氫-4-(3-氰基-4-(4-n-丙基環己基)苯氧 基)-5-(四氫-2,5-二羰基-3-呋喃基)-萘并[l,2-c]-呋喃-l,3-二酮、l,3,3a,4,5,9b-六氫-4-(3-氰基-4-(4-n·丁基環己基)苯 氧基)-5-(四氫-2,5-二羰基-3-呋喃基)·萘并[1,2-c]-呋喃 -1,3-二酮、l,3,3a,4,5,9b-六氫- 4-(3-氰基- 4-(4-n-戊基環己基) 200521207 苯氧基)-5-(四氫-2,5-二羰基-3-呋喃基)-萘并[1,2-c]-呋喃 -1,3-二酮、1,3,32,4,5,913-六氫-4-(3-氰基-4-(4-11-己基環己基) 苯氧基)-5-(四氫-2,5-二羰基-3_呋喃基)-萘并[1,2<]-呋喃 -1,3-二酮、1,3,3&,4,5,913-六氫-4-(3-氰基-4-(4-11-庚基環己基) 苯氧基)-5-(四氫-2,5-二羰基-3-呋喃基)-萘并[l,2-c]-呋喃 -1,3-二酮。 於此等之中以 1,3,3a,4,5,9b-六氫-4-(2,3-二氟-4-(4-η-丙 基環己基)苯氧基)-5-(四氫-2,5-二羰基-3-呋喃基)-萘并 [l,2-c]-呋喃-1,3-二酮、l,3,3a,4,5,9b-六氫-4-(2,3-二氟 · _4-(4-n-丁基環己基)苯氧基)-5-(四氫-2,5-二羰基-3-呋喃 基)-萘并[l,2-c]-呋喃-1,3-二酮、1,3,3&,4,5,9)3-六氫-4-(2,3-二氟- 4-(4-n-戊基環己基)苯氧基)-5-(四氫-2,5-二羰基-3-呋 喃基)-萘并[l,2-c]-呋喃-1,3-二酮、l,3,3a,4,5,9b-六氫 -4-(2,3-二氟- 4-(4·η-己基環己基)苯氧基)-5-(四氫-2,5-二羰 基-3-呋喃基)-萘并[l,2-c]-呋喃-1,3-二酮、l,3,3a,4,5,9b-A 氫-4-(2,3-二氟-4-(4-11-己基環己基)苯氧基)-5“四氫-2,5-二 羰基-3-呋喃基)-萘并[l,2-c]-呋喃-1,3-二酮、l,3,3a,4,5,9b- φ 六氫- 4-(2,3-二氟- 4-(4-η-庚基環己基)苯氧基)-5-(四氫-2,5-二羰基-3-呋喃基)-萘并[l,2-c]-呋喃-1,3-二酮; 1,3,3a,4,5,9b-六氫-4-(2,3-二氰基-4-(4-η-丙基環己基)苯 氧基)-5-(四氫-2,5-二羰基-3-呋喃基)-萘并[l,2-c]-呋喃 -1,3-二酮、l,3,3a,4,5,9b-六氫-4-(2,3-二氰基-4-(4-n-丁基環 己基)苯氧基)-5·(四氫- 2,5-二羰基-3·呋喃基)-萘并[l,2-c]-呋喃-l,3-二酮、l,3,3a,4,5,9b-六氫-4-(2,3-二氰基-4-(4-n-戊基環己基)苯氧基)-5-(四氫-2,5-二羰基-3-呋喃基)-萘并 -22- 200521207 [1,2<]-呋喃-1,3'二酮、1,3,38,4,5,91)-六氫-4-(2,3-二氰基 -4-(4-n-己基環己基)苯氧基)-5-(四氫·2,5-二羰基-3-呋喃 基)-萘并[1,2-c]-呋喃-1,3-二酮、l,3,3a,4,5,9b-六氫-4-(2,3-二氰基- 4-(4-η·庚基環己基)苯氧基)-5·(四氫- 2,5-二羰基-3· 呋喃基)-萘并[l,2-c^呋喃-l,3-二酮; l,3,3a,4,5,9b·六氫·4-(6-(4-η-丙基環己基)-3-噠畊氧 基)-5-(四氫-2,5-二羰基-3-呋喃基)-萘并[l,2-c]-呋喃-1,3-二酮、1,3,3&,4,5,913-六氫-4-(6-(4-11-丁基環己基)-3-噠阱氧 基)-5-(四氫-2,5-二羰基-3-呋喃基)-萘并[1,2-〇]-呋喃-1,3· φ 二酮、1,3,3&,4,5,91)-六氫-4-(6-(4-11-戊基環己基)-3-噠阱氧 基)-5-(四氫-2,5-二羰基-3-呋喃基)-萘并[l,2-c]·呋喃-1,3-二酮、1,3,3&,4,5,91)-六氫-4-(6-(4-11-己基環己基)-3-噠阱氧 基)-5-(四氫-2,5-二羰基-3-呋喃基)-萘并[l,2-c]-呋喃-1,3-二酮、1,3,3&,4,5,913-六氫-4-(6-(4-11-庚基環己基)-3-噠阱氧 基)-5-(四氫-2,5-二羰基-3-呋喃基)·萘并[l,2-c]-呋喃-1,3-二酮較佳。 本發明液晶配向劑中所含的聚合物之合成時所使用的其 φ 他四羧酸二酐,例如丁烷四羧酸二酐、1,2,3,心環丁烷四羧 酸二酐、1,2-二甲基-1,2,3,4-環丁烷四羧酸二酐、1,3-二甲 基-1,2,3,4-環丁烷四羧酸二酐、1,3-二氯-1,2,3,4-環丁烷四 羧酸二酐、1,2,3,4-四甲基-1,2,3,4-環丁烷四羧酸二酐、 1,2,3,4-環戊烷四羧酸二酐、1,2,4,5-環己烷四羧酸二酐、 3,3’,4,4’-二環己基四羧酸二酐、2,3,5-三羧基環戊基醋酸二 酐、3,5,6-三羧基原菠烷-2-醋酸二酐、2,3,4,5-四氫呋喃四 羧酸二酐、1,3,3&,4,5,913-六氫-5-(四氫-2,5-二羰基-3-呋喃 -23- 200521207-18- 200521207 < Tetracarboxylic dianhydride > A tetracarboxylic anhydride having a specific side chain, for example, 1,3,3a, 4,5,9b-hexahydro-4- (2,3-difluoro-4 -(4-n-propylcyclohexyl) phenoxy) -5- (tetrahydro-2,5-dicarbonyl-3-furanyl) -naphtho [l, 2-c] -furan-1,3 -Dione, 1,3,3a, 4,5,9b-A hydrogen-4- (2,3-difluoro-4- (4-n-butylcyclohexyl) phenoxy) -5- (tetra Hydrogen-2,5-dicarbonyl-3-furanyl) -naphtho [l, 2-c] -furan-1,3-dione, 1,3,3a, 4,5,9b-hexahydro- 4- ( 2,3-difluoro-4- (4-n-pentylcyclohexyl) phenoxy) -5- (tetrahydro-2,5-dicarbonyl-3-furanyl) -naphtho [l, 2_c ] -Furan-1,3-dione, 1,3,3a, 4,5,9b-hexahydro-4- (2,3-difluoro-4- (4-n-hexylcyclohexyl) phenoxy ) -5- (tetrahydro-2,5-dicarbonyl-3-furanyl) -naphtho [l, 2-c] -furan-1,3-dione, 1,3,3a, 4,5, 9b-hexahydro-4- (2,3-difluoro-4- (4-n-hexylcyclohexyl) phenoxy) -5- (tetrahydro-2,5-dicarbonyl-3-furanyl)- Naphtho [1,2-(:]-furan-1,3-dione, 1,3,3 &, 4,5,91) -hexahydro-4- (2,3-difluoro-4- ( 4-11-heptylcyclohexyl) phenoxy) -5- (tetrahydro-2,5-dicarbonyl-3-furanyl) -naphtho [1,2- c] -furan-1,3-dione; 1,3,3a, 4,5,9b-hexahydro-4- (2,3-dicyano-4- (4-n-propylcyclohexyl) Phenoxy) -5- (tetrahydro-2,5-dicarbonyl-3-furanyl) -naphtho [1,2-c] -furan-1,3-dione, 1,3,3 &, 4,5,91) -hexahydro-4- (2,3-dicyano-4- (4-11-butylcyclohexyl) phenoxy) -5- (tetrahydro-2,5-dicarbonyl -3_furanyl) -naphtho [l, 2-c; l · furan · l, 3-dione, l, 3,3a, 4,5,9b-hexahydro-4- (2,3-di Cyano-4- (4-n_pentylcyclohexyl) phenoxy) -5- (tetrahydro-2,5-dicarbonyl-3-furanyl) -naphtho [1,2-(:]-furan -1,3-dione, 1,3,3 &, 4,5,91) -hexahydro-4- (2,3-dicyano_4- (4-n-hexylcyclohexyl) phenoxy ) -5- (tetrahydro-2,5-dicarbonyl-3-furanyl) -naphtho [1,2-c] -furan-1,3-dione, 1,3,3a, 4,5, 9b-hexahydro-4- (2,3-dicyano-4- (4 · η-heptylcyclohexyl) phenoxy) -5- (tetrahydro-2,5-dicarbonyl-3- 200521207 furan ) -Naphtho [l, 2-c] -furan-1,3-dione; 1,3,3a, 4,5,9b-hexahydro-4- (6- (4-n-propyl ring) Hexyl) -3-pyridoxyl) -5- (tetrahydro-2,5-dicarbonyl-3-furanyl) -naphtho [l, 2-c] -furan-1,3-dione, 1 , 3,3 ^ 4 , 5,91 hexahydro-4- (6- (4-11-butylcyclohexyl) -3-pyridyloxy) -5- (tetrahydro · 2,5-dicarbonyl-3-furyl)- Naphtho [l, 2 · c] -furan-1,3-diketone, 1,3,3a, 4,5,9b-hexahydro-4- (6- (4-n-pentylcyclohexyl)- : 3-pyridyloxy) -5- (tetrahydro-2,5-dicarbonyl-3-furanyl) -naphtho [l, 2-c] -furan-1,3-dione, 1,3 , 33,4,5,91) -hexahydro-4- (6- (4-11-hexylcyclohexyl) -3-pyridoxyl) -5- (tetrahydro-2,5-dicarbonyl-3 -Furanyl) -naphtho [1,2 <]-furan-1,3- φdione, 1,3,38,4,5,913-hexahydro-4- (6- (4-11-heptyl ring Hexyl) -3-pyridyloxy) -5- (tetrahydro-2,5-dicarbonyl-3-furanyl) -naphtho [l, 2-c] -furan-1,3-dione; l , 3,3a, 4,5,9b-hexahydro-4- (2-fluoro-4- (4-n-propylcyclohexyl) phenoxy) -5- (tetrahydro-2,5-dicarbonyl -3-furanyl) -naphtho [l, 2-c] -furan-1,3-dione, 1,3,3 &, 4,5,913-hexahydro-4- (2-fluoro-4- ( 4-11-butylcyclohexyl) phenoxy) -5- (tetrahydro-2,5-dicarbonyl-3-furanyl) -naphtho [l, 2-c] -furan-1,3-di Ketone, 1,3,3a, 4,5,9b-hexahydro-4- (2-fluoro-4- (4-n-pentylcyclohexyl) phenoxy · yl) -5- (tetrahydro-2, 5-dicarbonyl-3 · Ranyl) -naphtho [l, 2-c] -furan-l, 3-dione, 1,3,3a, 4,5,9b-hexahydro-4- (2-fluoro-4- (4- n-hexylcyclohexyl) phenoxy) -5- (tetrahydro-2,5-dicarbonyl-3-furanyl) -naphtho [1,2-c] -furan-1,3-dione, 1 , 3,3 &, 4,5,91 ^ hexahydro-4- (2-fluoro-4- (4-11-heptylcyclohexyl) phenoxy) -5- (tetrahydro-2,5-di Carbonyl-3-furanyl) -naphtho [l, 2-c; l · furan-l, 3-dione; l, 3,3a, 4,5,9b-hexahydro-4- (3-fluoro- 4- (4-η · propylcyclohexyl) phenoxy) -5- (tetrahydro-2,5-dicarbonyl-3-furanyl) -naphtho [1,2-〇] -furan-1, 3- -20- 200521207 dione, 1,3,32,4,5,913-hexahydro-4- (3-fluoro-4- (4-11-butylcyclohexyl) phenoxy) -5- (tetra Hydrogen-2,5-dicarbonyl-3-furanyl) -naphtho [l, 2-c] -furan-1,3-dione, 1,3,3a, 4,5,9b-hexahydro-4 -(3-fluoro-4- (4-n-pentylcyclohexyl) phenoxy) -5- (tetrahydro-2,5-dicarbonyl-3-furanyl) -naphtho [l, 2-c ] -Furan-1,3-dione, 1,3,32,4,5,91) -hexahydro-4- (3-fluoro-4- (4-11-hexylcyclohexyl) phenoxy)- 5- (tetrahydro-2,5-dicarbonyl-3-furanyl) -naphtho [l, 2 · c; l · furan-1,3-dione, 1,3,3a, 4,5,9b -Hexahydro-4- ( 3-fluoro-4- (4-n-heptylcyclohexyl) phenoxy) -5- (tetrahydro-2,5-dicarbonyl-3-furanyl) -naphtho [l, 2-c]- Furan-1,3-dione; 1,3,3a, 4,5,9b-hexahydro-4- (2-cyano-4- (4-η-propylcyclohexyl) phenoxy) -5 -(Tetrahydro-2,5-dicarbonyl-3-furanyl) -naphtho [l, 2-c ^ furan-l, 3-dione, 1,3,3a, 4,5,9b-hexahydro -4- (2-cyano-4- (4-n · butylcyclohexyl) phenoxy) -5- (tetrahydro-2,5-dicarbonyl-3 · furanyl) -naphtho [l, 2-c] -furan-1,3-dione, 1,3,38,4,5,913-hexahydro-4- (2-cyano-4- (4-11-pentylcyclohexyl) phenoxy ) -5- (tetrahydro-2,5-dicarbonyl-3-furanyl) -naphtho [l, 2-c] -furan-1,3-dione, 1,3,3a, 4,5, 9b-hexahydro- 4- (2-cyano- 4- (4-n-hexylcyclohexyl) phenoxy) -5- (tetrahydro-2,5-dicarbonyl-3-furanyl) -naphtho [1,2-〇] -furan-1,3-dione, 1,3,3 &, 4,5,91) -hexahydro-4- (2-cyano-4- (4-11-heptane Cyclohexyl) phenoxy) -5- (tetrahydro-2,5-dicarbonyl-3-furanyl) -naphtho [l, 2-c] -furan-1,3 · dione; 1,3 , 3a, 4,5,9b-hexahydro-4- (3-cyano-4- (4-n-propylcyclohexyl) phenoxy) -5- (tetrahydro-2,5-dicarbonyl- 3- Ranyl) -naphtho [l, 2-c] -furan-l, 3-dione, 1,3,3a, 4,5,9b-hexahydro-4- (3-cyano-4- (4 -n · butylcyclohexyl) phenoxy) -5- (tetrahydro-2,5-dicarbonyl-3-furanyl) · naphtho [1,2-c] -furan-1,3-dione , L, 3,3a, 4,5,9b-hexahydro- 4- (3-cyano-4- (4-n-pentylcyclohexyl) 200521207 phenoxy) -5- (tetrahydro-2, 5-dicarbonyl-3-furanyl) -naphtho [1,2-c] -furan-1,3-dione, 1,3,32,4,5,913-hexahydro-4- (3-cyano -4- (4-11-hexylcyclohexyl) phenoxy) -5- (tetrahydro-2,5-dicarbonyl-3_furanyl) -naphtho [1,2 <]-furan-1,3 -Dione, 1,3,3 &, 4,5,913-hexahydro-4- (3-cyano-4- (4-11-heptylcyclohexyl) phenoxy) -5- (tetrahydro-2 , 5-dicarbonyl-3-furanyl) -naphtho [l, 2-c] -furan-1,3-dione. Among these, 1,3,3a, 4,5,9b-hexahydro-4- (2,3-difluoro-4- (4-η-propylcyclohexyl) phenoxy) -5- (Tetrahydro-2,5-dicarbonyl-3-furanyl) -naphtho [l, 2-c] -furan-1,3-dione, 1,3,3a, 4,5,9b-hexahydro -4- (2,3-difluoro · _4- (4-n-butylcyclohexyl) phenoxy) -5- (tetrahydro-2,5-dicarbonyl-3-furanyl) -naphtho [ 1,2-c] -furan-1,3-dione, 1,3,3 &, 4,5,9) 3-hexahydro-4- (2,3-difluoro-4- (4-n -Pentylcyclohexyl) phenoxy) -5- (tetrahydro-2,5-dicarbonyl-3-furanyl) -naphtho [l, 2-c] -furan-1,3-dione, l , 3,3a, 4,5,9b-hexahydro-4- (2,3-difluoro-4- (4 · η-hexylcyclohexyl) phenoxy) -5- (tetrahydro-2,5- Dicarbonyl-3-furanyl) -naphtho [l, 2-c] -furan-1,3-dione, 1,3,3a, 4,5,9b-A hydrogen-4- (2,3- Difluoro-4- (4-11-hexylcyclohexyl) phenoxy) -5 "tetrahydro-2,5-dicarbonyl-3-furanyl) -naphtho [l, 2-c] -furan-1 , 3-dione, 1,3,3a, 4,5,9b- φ hexahydro- 4- (2,3-difluoro- 4- (4-η-heptylcyclohexyl) phenoxy) -5 -(Tetrahydro-2,5-dicarbonyl-3-furanyl) -naphtho [l, 2-c] -furan-1,3-dione; 1,3,3a, 4,5,9b-hexa Hydrogen-4- (2 3-dicyano-4- (4-η-propylcyclohexyl) phenoxy) -5- (tetrahydro-2,5-dicarbonyl-3-furanyl) -naphtho [l, 2-c ] -Furan-1,3-dione, 1,3,3a, 4,5,9b-hexahydro-4- (2,3-dicyano-4- (4-n-butylcyclohexyl) benzene Oxy) -5 · (tetrahydro-2,5-dicarbonyl-3 · furanyl) -naphtho [l, 2-c] -furan-1,3-dione, 1,3,3a, 4, 5,9b-hexahydro-4- (2,3-dicyano-4- (4-n-pentylcyclohexyl) phenoxy) -5- (tetrahydro-2,5-dicarbonyl-3- Furyl) -naphtho-22- 200521207 [1,2 <]-furan-1,3'dione, 1,3,38,4,5,91) -hexahydro-4- (2,3-di Cyano-4- (4-n-hexylcyclohexyl) phenoxy) -5- (tetrahydro · 2,5-dicarbonyl-3-furanyl) -naphtho [1,2-c] -furan- 1,3-diketone, 1,3,3a, 4,5,9b-hexahydro-4- (2,3-dicyano-4- (4-η · heptylcyclohexyl) phenoxy)- 5 · (tetrahydro-2,5-dicarbonyl-3 · furanyl) -naphtho [l, 2-c ^ furan-1,3-dione; 1,3,3a, 4,5,9b · hexa Hydrogen · 4- (6- (4-η-propylcyclohexyl) -3-pyridyloxy) -5- (tetrahydro-2,5-dicarbonyl-3-furanyl) -naphtho [l, 2-c] -furan-1,3-dione, 1,3,3 &, 4,5,913-hexahydro-4- (6- (4-11-butylcyclohexyl) -3-pyridine ) -5- (tetrahydro-2,5-dicarbonyl-3-furanyl) -naphtho [1,2-〇] -furan-1,3 · φ dione, 1,3,3 &, 4 , 5,91) -hexahydro-4- (6- (4-11-pentylcyclohexyl) -3-pyridyloxy) -5- (tetrahydro-2,5-dicarbonyl-3-furanyl ) -Naphtho [l, 2-c] · furan-1,3-dione, 1,3,3 &, 4,5,91) -hexahydro-4- (6- (4-11-hexyl ring) Hexyl) -3-pyridyloxy) -5- (tetrahydro-2,5-dicarbonyl-3-furanyl) -naphtho [l, 2-c] -furan-1,3-dione, 1 , 3,3 &, 4,5,913-hexahydro-4- (6- (4-11-heptylcyclohexyl) -3-pyridyloxy) -5- (tetrahydro-2,5-dicarbonyl- 3-furyl) · naphtho [l, 2-c] -furan-1,3-dione is preferred. Other tetracarboxylic dianhydrides used in the synthesis of the polymer contained in the liquid crystal alignment agent of the present invention, such as butanetetracarboxylic dianhydride, 1,2,3, cardiocyclobutanetetracarboxylic dianhydride 1,1,2-dimethyl-1,2,3,4-cyclobutane tetracarboxylic dianhydride, 1,3-dimethyl-1,2,3,4-cyclobutane tetracarboxylic dianhydride , 1,3-dichloro-1,2,3,4-cyclobutane tetracarboxylic dianhydride, 1,2,3,4-tetramethyl-1,2,3,4-cyclobutane tetracarboxylic acid Acid dianhydride, 1,2,3,4-cyclopentanetetracarboxylic dianhydride, 1,2,4,5-cyclohexanetetracarboxylic dianhydride, 3,3 ', 4,4'-bicyclo Hexyltetracarboxylic dianhydride, 2,3,5-tricarboxycyclopentylacetic dianhydride, 3,5,6-tricarboxyoranidine-2-acetic dianhydride, 2,3,4,5-tetrahydrofuran tetra Carboxylic dianhydride, 1,3,3 &, 4,5,913-hexahydro-5- (tetrahydro-2,5-dicarbonyl-3-furan-23- 200521207

基)-萘并[l,2-c]-呋喃-1,3-二酮、1,3,3&,4,5,913-六氫-5-甲基 -5-(四氫-2,5-二羰基-3-呋喃基)-萘并[1,2乂]-呋喃-1,3-二 酮、1,3,3&,4,5,91)-六氫-5-乙基-5-(四氫-2,5-二羰基-3-呋喃 基)-萘并[l,2-c]-呋喃-1,3-二酮、1,3,32,4,5,91)-六氫-7-甲基 -5-(四氫-2,5-二羰基-3-呋喃基)-萘并[l,2-c]-呋喃-1,3-二 酮、1,3,3&,4,5,91)-六氫-7-乙基-5-(四氫-2,5-二羰基-3-呋喃 基)-萘并[1,2-c]-呋喃-1,3-二酮、1,3,3&,4,5,91)-六氫-8-甲基 -5-(四氫-2,5-二羰基-3-呋喃基)-萘并[l,2-c]-呋喃-1,3-二 酮、l,3,3a,4,5,9b-六氫·8-乙基-5-(四氫-2,5-二羰基-3-呋喃 基)-萘并[1,2-c]-呋喃-1,3-二酮、l,3,3a,4,5,9b-六氫-5,8-二 甲基- 5-(四氫- 2,5-二羰基-3-呋喃基)-萘并[l,2-c]-呋喃-l,3-二酮、5-(2,5-二羰基四氫呋喃基)-3-甲基-3-環己烯-l,2-二 羧酸二酐、二環[2,2,2]-辛-7-烯-2,3,5,6-四羧酸二酐、3-氧 化二環[3,2, 1]辛烷- 2,4-二酮-6-螺旋- 3’·(四氫呋喃-2’,5’-二 酮)、以下述式(X)及(XI)所示化合物等之脂肪族及脂環式四 羧酸二酐;) -Naphtho [l, 2-c] -furan-1,3-dione, 1,3,3 &, 4,5,913-hexahydro-5-methyl-5- (tetrahydro-2,5 -Dicarbonyl-3-furanyl) -naphtho [1,2 乂] -furan-1,3-dione, 1,3,3 &, 4,5,91) -hexahydro-5-ethyl- 5- (tetrahydro-2,5-dicarbonyl-3-furanyl) -naphtho [l, 2-c] -furan-1,3-dione, 1,3,32,4,5,91) -Hexahydro-7-methyl-5- (tetrahydro-2,5-dicarbonyl-3-furanyl) -naphtho [l, 2-c] -furan-1,3-dione, 1,3 , 3 &, 4,5,91) -hexahydro-7-ethyl-5- (tetrahydro-2,5-dicarbonyl-3-furanyl) -naphtho [1,2-c] -furan- 1,3-dione, 1,3,3 &, 4,5,91) -hexahydro-8-methyl-5- (tetrahydro-2,5-dicarbonyl-3-furanyl) -naphtho [1,2-c] -furan-1,3-dione, 1,3,3a, 4,5,9b-hexahydro · 8-ethyl-5- (tetrahydro-2,5-dicarbonyl- 3-furyl) -naphtho [1,2-c] -furan-1,3-dione, 1,3,3a, 4,5,9b-hexahydro-5,8-dimethyl-5 (Tetrahydro-2,5-dicarbonyl-3-furanyl) -naphtho [l, 2-c] -furan-1,3-dione, 5- (2,5-dicarbonyltetrahydrofuranyl) -3 -Methyl-3-cyclohexene-1,2-dicarboxylic dianhydride, bicyclo [2,2,2] -oct-7-ene-2,3,5,6-tetracarboxylic dianhydride, 3-oxidized bicyclo [3,2, 1] Aliphatic and alicyclic octane-2,4-dione-6-helix-3 '· (tetrahydrofuran-2', 5'-dione), compounds represented by the following formulae (X) and (XI), etc. Tetracarboxylic dianhydride

(X)(X)

-24- (XI) 200521207 (其中’ R8及R]°係爲具有芳香環之2價有機基,R9及 係爲氫原子或烷基,數個存在的R9及R 1 1可以相同或不同) 例如均苯四甲酸二酐、3,3,,4,4,-二苯甲酮四羧酸二酐、 3,3,4,4’-聯苯四羧酸二酐、1,4,5,8-萘四羧酸二酐、2,3,6,7-萘四羧酸二酐、3,3,,4,4,-聯苯醚四羧酸二酐、3,3,,4,4、二 甲基二苯基矽烷四羧酸二酐、3,3’,4,4’-四苯基矽烷四竣酸 二酐、1,2,3,4-呋喃四羧酸二酐、4,4’-雙(3,4-二羧基苯氧基) 二苯基硫醚二酐、4,4、雙(3,4-二羧基苯氧基)二苯基酞二 酐、4,4’-雙(3,4-二羧基苯氧基)二苯基酞二酐、4,4,-雙(3,4-二羧基苯氧基)二苯基丙烷二酐、3,3,,4,4,-過氟化異亞丙基 二酞酸二酐、3,3’,4,4’-聯苯四羧酸二酐、雙(酞酸)苯基氧 化膦二酐、P -亞苯基-雙(三苯基酞酸)二酐、m-亞苯基-雙(三 苯基酞酸)二酐、雙(三苯基酞酸)-4,4’·二苯醚二酐、雙(三 苯基酞酸)-4,4二苯基甲烷二酐、乙二醇-雙(偏苯三甲酸 酯)、丙二醇-雙(偏苯三甲酸酯)、1,4 - 丁烷二醇-雙(偏苯三 甲酸酯)、1,6-己烷二醇-雙(偏苯三甲酸酯)、1,8_辛烷二醇 雙(偏苯三甲酸酯)、2,2 -雙(4 -羥基苯基)丙烷-雙(偏苯三甲 酸酯)、下述式(18)〜(21)所示化合物等之芳香族四羧酸二 酐。此等可單獨一種使用或2種以上組合使用。 【化1 3】 -25- 200521207-24- (XI) 200521207 (where 'R8 and R] ° are divalent organic groups with aromatic rings, R9 and R are hydrogen atoms or alkyl groups, and several R9 and R 1 1 may be the same or different. For example pyromellitic dianhydride, 3,3,, 4,4, -benzophenone tetracarboxylic dianhydride, 3,3,4,4'-biphenyltetracarboxylic dianhydride, 1,4,5 , 8-naphthalenetetracarboxylic dianhydride, 2,3,6,7-naphthalenetetracarboxylic dianhydride, 3,3,, 4,4, -diphenyl ether tetracarboxylic dianhydride, 3,3,, 4 4,4 Dimethyldiphenylsilane tetracarboxylic dianhydride, 3,3 ', 4,4'-tetraphenylsilane tetracarboxylic dianhydride, 1,2,3,4-furantetracarboxylic dianhydride 4,4'-bis (3,4-dicarboxyphenoxy) diphenyl sulfide dianhydride, 4,4, bis (3,4-dicarboxyphenoxy) diphenylphthalic dianhydride, 4 , 4'-bis (3,4-dicarboxyphenoxy) diphenylphthalic anhydride, 4,4, -bis (3,4-dicarboxyphenoxy) diphenylpropanedianhydride, 3,3 ,, 4,4, -Perfluorinated isopropylidene diphthalic dianhydride, 3,3 ', 4,4'-biphenyltetracarboxylic dianhydride, bis (phthalic acid) phenylphosphine oxide dianhydride, P -phenylene-bis (triphenylphthalic acid) dianhydride, m-phenylene-bis (triphenylphthalic acid) dianhydride, bis Triphenylphthalic acid) -4,4 '· diphenyl ether dianhydride, bis (triphenylphthalic acid) -4,4diphenylmethane dianhydride, ethylene glycol-bis (trimellitic acid triester), Propylene glycol-bis (trimellitic acid ester), 1,4-butanediol-bis (trimellitic acid ester), 1,6-hexanediol-bis (trimellitic acid ester), 1,8 _Octanediol bis (trimellitic acid ester), 2,2-bis (4-hydroxyphenyl) propane-bis (trimellitic acid ester), compounds represented by the following formulae (18) to (21) And other aromatic tetracarboxylic dianhydrides. These can be used alone or in combination of two or more. [Chem. 1 3] -25- 200521207

於此等之中,就具有良好的液晶配向性而言以丁烷四羧 酸二酐、1,2,3,4-環丁烷四羧酸二酐、1,3-二甲基-1,2,3,4-環丁烷四羧酸二酐、1,2,3,4-環戊烷四羧酸二酐、1,2,4,5-環己烷四羧酸二酐、2,3,5 -三羧基環戊基醋酸二酐、5 - ( 2,5 - -26- 200521207 一碳基四氯咲喃基)-3 -甲基-3 -己錄-1,2 -二殘酸二肝、 1,3,3&,4,5,91)-六氫-5-(四氫-2,5-二羰基-3-呋喃基)萘并 [l,2-c]呋喃-1,3-二酮、l,3,3a,4,5,9b -六氫-8-甲基-5-(四氫 -2,5-二羰基-3-呋喃基)萘并[1,2-(:]呋喃-1,3-二酮、 1,3,3a,4,5,9b -六氫-5,8-二甲基- 5- (四氫-2,5·二羰基-3-呋喃 基)萘并[l,2-c]呋喃-1,3-二酮、二環[2,2,2]-辛-7-烯-2,3,5,6-四羧酸二酐、3-氧化二環[3,2,1]辛烷-2,4-二酮-6-螺旋 -3’-(四氫呋喃-2,,5,-二酮)、均苯四甲酸二酐、3,3,,4,4、二 苯甲酮四羧酸二酐、3,3’,4,4’聯苯酞四羧酸二酐、 萘四羧酸二酐、以上述式(X)所示化合物中下述式(22)〜(24) 所示化合物及上述式(XI)所示化合物中下述式(2 5 )所示化 合物較佳。更佳者爲1,2,3,4-環丁烷四羧酸二酐、1,3_二甲 基-1,2,3,4 -環丁烷四羧酸二酐、I,2,4,5—環己烷四羧酸二 酐、2,3,5-三羧基環戊基醋酸二酐、1,3,3^4,5,91)-六氫-5-(四 氫-2,5-二羰基-3-呋喃基)-萘并[1,2_(:]呋喃-1,3-:=:@11、 1,3山,4,5,9卜六氫-8-甲基-5-(四氫-2,5〜擬基-3-味喃基)- 環[3,2,1]辛烷-2,4-二酮 均苯四甲酸二酐及下述 萘并[l,2-c]呋喃-1,3-二酮、3-氧化二 -6-螺旋- 3’-(四氫呋喃-2,5、二酮)、 式(22)所示化合物。Among these, butane tetracarboxylic dianhydride, 1,2,3,4-cyclobutane tetracarboxylic dianhydride, and 1,3-dimethyl-1 are considered in terms of having good liquid crystal alignment. , 2,3,4-cyclobutanetetracarboxylic dianhydride, 1,2,3,4-cyclopentanetetracarboxylic dianhydride, 1,2,4,5-cyclohexanetetracarboxylic dianhydride, 2,3,5 -tricarboxycyclopentylacetic dianhydride, 5-(2,5--26-200521207 one-carbon tetrachlorosulfanyl) -3 -methyl -3 -Hexyl-1,2- Dihepatic acid diliver, 1,3,3 &, 4,5,91) -hexahydro-5- (tetrahydro-2,5-dicarbonyl-3-furanyl) naphtho [l, 2-c] Furan-1,3-dione, 1,3,3a, 4,5,9b -hexahydro-8-methyl-5- (tetrahydro-2,5-dicarbonyl-3-furanyl) naphtho [ 1,2-(:) furan-1,3-dione, 1,3,3a, 4,5,9b -hexahydro-5,8-dimethyl-5-(tetrahydro-2,5 · di Carbonyl-3-furanyl) naphtho [l, 2-c] furan-1,3-dione, bicyclo [2,2,2] -oct-7-ene-2,3,5,6-tetra Carboxylic dianhydride, 3-oxobicyclo [3,2,1] octane-2,4-dione-6-spiral-3 '-(tetrahydrofuran-2,5, -dione), pyromellitic Formic acid dianhydride, 3,3,4,4, benzophenone tetracarboxylic dianhydride, 3,3 ', 4,4'biphenylphthalate dianhydride, naphthalene tetra Among the compounds represented by the formula (X), acid dianhydrides, compounds represented by the following formulae (22) to (24), and compounds represented by the formula (XI) are preferred. More preferred are 1,2,3,4-cyclobutanetetracarboxylic dianhydride, 1,3-dimethyl-1,2,3,4-cyclobutanetetracarboxylic dianhydride, I, 2, 4,5-cyclohexanetetracarboxylic dianhydride, 2,3,5-tricarboxycyclopentylacetic dianhydride, 1,3,3 ^ 4,5,91) -hexahydro-5- (tetrahydro- 2,5-dicarbonyl-3-furanyl) -naphtho [1,2-(:) furan-1,3-: =: @ 11, 1,3, 4,5,9 hexahydro-8- Methyl-5- (tetrahydro-2,5 ~ peptidyl-3-amidinyl) -cyclo [3,2,1] octane-2,4-dione pyromellitic dianhydride and the following naphthalene [1,2-c] furan-1,3-dione, 3-oxo-6-6-helix-3 '-(tetrahydrofuran-2,5, dione), and a compound represented by formula (22).

27- 20052120727- 200521207

I .23)I .23)

ο -ί ·(25) ο <聚醯胺酸之合成> 聚醯胺酸合成反應時使用的四羧酸二酐與二胺之使用比 例,對1當量二胺之胺基而言四羧酸二酐之酸酐基以0.2 〜2當量較佳,以0.3〜1.2當量更佳。 聚醯胺酸之合成反應於有機溶劑中,以-20〜150t較佳, 更佳者爲〇〜1 〇〇°C之溫度條件下進行。此處,有機溶劑只 要是可溶解合成的聚醯胺酸即可,沒有特別的限制,例如 -28- 200521207 1-甲基-2-吡咯烷酮、N,Nc甲基乙醯胺、ν,Ν -二甲基甲醯 胺、二甲基亞酞、丁內酯、四甲基尿素、六甲基磷化三 醯胺等之非質子系極性溶劑;m _甲酚、二甲苯酚、苯酚、 鹵化苯酚等之苯酚系溶劑。而且,有機溶劑之使用量(α)以 四羧酸二酐及二胺化合物之總量(β)、對反應液之全量(α + β) 而言爲0.1〜30重量%較佳。 而且’上述有機溶劑可在不會使生成的聚醯胺酸析出的 範圍內,倂用聚醯胺酸之貧溶劑的醇類、酮類、酯類、醚 類、鹵化烴類、烴類等。該貧溶劑之具體例如甲醇、乙醇、馨 異丙醇、環己醇、4-羥基-4-甲基-2-戊酮、乙二醇、丙二醇、 1,4 - 丁二醇、三乙二醇、乙二醇單甲醚、乳酸乙酯、乳酸丁 酯、丙酮、甲基乙酮、甲基異丁酮、環己酮、醋酸甲酯、 醋酸乙酯、醋酸丁酯、甲基甲氧基丙酸酯、乙基乙氧基丙 酸酯、草酸二乙酯、丙酸二乙酯、二乙醚、乙二醇甲醚、 乙二醇乙醚、乙二醇-η_丙醚、乙二醇小丙醚、乙二醇-η-丁醚、乙二醇二甲醚、乙二醇乙醚乙酸酯、二乙二醇二甲 醚、二乙二醇二乙醚、二乙二醇單甲醚、二乙二醇單乙醚、 · 二乙二醇單甲醚乙酸酯、二乙二醇單乙醚乙酸酯、四氫呋 喃、二氯甲烷、1,2-二氯乙烷、1,4-二氯丁烷、三氯乙烷、 氯苯、〇-二氯苯、己烷、庚烷、辛烷、苯、甲苯、二甲苯 等。 如上所述,製得溶解聚醯胺酸所成的反應溶液。然後, 在大量貧溶劑中注入該反應溶液以得析出物,藉由在減壓 下乾燥該析出物,可製得聚醯胺酸。另外,藉由使該聚醯 胺酸再次溶解於有機溶劑中,進行一次或多次貧溶劑析出 -29- 200521207 的工程,可精製聚醯胺酸。 <醯亞胺化聚合物之合成> 構成本發明液晶配向劑之醯亞胺化聚合物,可藉由使上 述聚醯胺酸脫水閉環予以合成。聚醯胺酸之脫水閉環可藉 由⑴使聚醯胺酸加熱的方法、或(II)使聚醯胺酸溶解於有機 溶劑且在該溶液中添加脫水劑及脫水閉環觸媒、視其所需 加熱的方法進行。而且,本發明所使用的醯亞胺化聚合物 中,亦可包含部分脫水閉環的醯亞胺化率(以聚合物中全部 重複單位之形成醯亞胺環所成重複單位的比例%表示者)小 φ 於100%之醯亞胺化聚合物。 使上述(I)之聚醯胺酸加熱的方法之反應溫度,以50〜 2 00°(:較佳,更佳者60〜170°(:。反應溫度小於50°(:時脫水 閉環反應無法充分進行,反應溫度大於200°C時所得的醯亞 胺化聚合物(B)之分子量降低。 另外,上述(II)之聚醯胺酸溶液中添加脫水劑及脫水閉環 觸媒的方法中,脫水劑例如可使用醋酸酐、丙酸酐、三氟 化醋酸酐等之酸酐。脫水劑之使用量視企求的醯亞胺化率 φ 而定,以對1單位聚醯胺酸重複單位而言爲0.01〜20莫耳 較佳。此外,脫水閉環觸媒例如可使用吡啶、三甲基毗啶、 二甲基吡啶、三乙胺等之三級胺。然而,不受此等所限制。 脫水閉環觸媒之使用量以對1莫耳使用的脫水劑而言爲 0.0 1〜1 0莫耳較佳。醯亞胺化率係隨著上述脫水劑、脫水 閉環劑愈多時愈高。而且,脫水閉環反應使用的有機溶劑, 例如聚醯胺酸合成所使用者例示的有機溶劑。然後,脫水 閉環反應之反應溫度以0〜18(TC較佳,更佳者爲10〜 -30- 200521207 · 1 5 〇 °c。另外,對如此所得的反應溶液而言藉由進行與聚醯 胺酸之精製方法相同的操作,可精製醯亞胺化聚合物。 <末端修飾型聚合物> 聚醯胺酸及醯亞胺化聚合物,亦可以爲分子量經調節的 末端修飾型者。藉由使用該末端修飾型聚合物,在不會損 害本發明之效果下可改善液晶配向劑之塗覆特性。該末端 修飾型者,於聚醯胺酸合成時可藉由在反應系中添加酸 酐、單胺化合物、單異氰酸酯化合物等合成。此處,酸酐 例如馬來酸酐、酞酸酐、衣康酸酐、η-癸基丁二酸酐、η- · 十二院基丁二酸酐、η -十四院基丁二酸酐、η -十六院基丁 二酸酐等。而且,單胺化合物例如苯胺、環己胺、η-丁胺、 η -戊胺、η -己胺、η -庚胺、η -辛胺、η -壬胺、η -癸胺、η -十 一胺、η -十二胺、η -十三胺、η -十四胺、η -十五胺、η -十六 胺、η-十七胺、η-十八胺、η-二十胺等。此外,單異氰酸酯 化合物例如苯基異氰酸酯、萘基異氰酸酯等。 <液晶配向劑> 本發明之液晶配向劑係爲在有機溶劑中溶解含有具有特 | 定側鏈之聚合物、通常爲聚醯胺酸及/或醯亞胺化聚合物予 以構成。 調製本發明液晶配向劑時之溫度以〇〜200°C較佳,更佳 者爲20〜60 °C。 構成本發明液晶配向劑之有機溶劑,例如聚醯胺酸之合 成反應所使用者例示的溶劑。而且,可倂用適當選擇聚醯 胺酸之合成反應時所倂用者例示的貧溶劑。於此等之中, 以1-甲基-2-吡咯烷酮、表面張力爲32dyn/cm以下之溶劑較 -31 - 200521207 佳。表面張力爲32dyn/cm以下之溶劑,例如4-羥基-4 -甲基 -2-庚酮、乙二醇單甲醚、乳酸丁酯、醋酸丁酯、甲基甲氧 基丙酸酯、乙基乙氧基丙酸酯、乙二醇甲醚、乙二醇乙醚、 乙二醇- η-丙醚、乙二醇-i-丙醚、乙二醇- η-丁醚、乙二醇二 甲醚、乙二醇乙醚乙酸酯、二乙二醇二甲醚、二乙二醇二 乙醚、二乙二醇單甲醚、二乙二醇單乙醚、二乙二醇單甲 醚乙酸酯、二乙二醇單乙醚乙酸酯等。 1-甲基-2-吡咯烷與表面張力爲32dyn/cm以下之溶劑的比 例,以1-甲基-2-吡咯烷酮爲20〜60重量%、表面張力爲 32dyn以下之溶劑爲80〜40重量%較佳。該比例在範圍外 時,由於會引起聚合物析出且水平性不充分,無法得到充 分的印刷性。 本發明液晶配向劑之固成份濃度,可考慮黏性、揮發性 等予以選擇,較佳者爲1〜1 0重量%。換言之,本發明之液 晶配向劑塗覆於基板表面形成液晶配向膜塗膜,惟固成份 濃度小於1重量%時該塗膜之膜厚過小、無法製得良好的液 晶配向膜,固成份濃度大於1 0重量%時塗膜之膜厚過大、 無法製得良好的液晶配向膜,且液晶配向劑之黏性增大, 塗覆特性不佳。 本發明之液晶配向劑,在不會損害目的之物性範圍內, 就可提高對基板表面之黏合性而言亦包含含官能性矽烷之 化合物、環氧化合物。該含官能性矽烷化合物例如3-胺基 丙基三甲氧基矽烷、3-胺基丙基三乙氧基矽烷、2-胺基丙 基三甲氧基矽烷、2-胺基丙基三乙氧基矽烷、N_ (2-胺基乙 基)-3-胺基丙基三甲氧基矽烷、N-(2-胺基乙基)-3-胺基丙基 200521207 甲基二甲氧基矽烷、3 -脲基丙基三曱氧基矽烷、3 -脲基丙 基三乙氧基矽烷、N -乙氧基羰基-3 -胺基丙基三甲氧基矽 院、N -乙氧基鑛基-3-胺基丙基三乙氧基砂院、N -三乙氧基 甲矽烷基丙基三乙三胺、N·三甲氧基甲矽烷基丙基三乙三 胺、10-三甲氧基甲矽烷基-1,4,7-三氮癸烷、10-三乙氧基甲 矽烷基-1,4,7-三氮癸烷、9-三甲氧基甲矽烷基-3,6-二氮壬 基乙酸酯、9-三乙氧基甲矽烷基-3,6-二氮壬基乙酸酯、N-苯甲基-3-胺基丙基三甲氧基矽烷、N -苯甲基-3_胺基丙基三 乙氧基矽烷、N-苯基-3-胺基丙基三甲氧基矽烷、N-苯基-3- φ 胺基丙基三乙氧基矽烷、N -雙(環氧乙烷)-3 -胺基丙基三甲 氧基砂院、N -雙(環氧乙院)-3 -胺基丙基三乙氧基砂院等。 該含環氧基之化合物例如乙二醇二環氧丙醚、聚乙二醇二 環氧丙醚、丙二醇二環氧丙醚、三丙二醇二環氧丙醚、聚 丙二醇二環氧丙醚、新戊醇二環氧丙醚、;1,6_己二醇二環氧 丙醚、丙三醇二環氧丙醚、2,2 -二溴化新戊醇二環氧丙醚、 1,3,5,6 -四環氧丙基- 2,4-己二醇、N,N,N’,N’·四環氧丙基- m-二苯二甲胺、1,3-雙(N,N-二環氧丙基胺基甲基)環己烷、 φ N,N,N’,N’-四環氧丙基-4,4’-二胺基二苯基甲烷、3-(N-烯丙 基-N-環氧丙基)胺基丙基三甲氧基矽烷、3-(N,N-二環氧丙 基)胺基丙基三甲氧基矽烷等。 <液晶顯示元件> 使用本發明之液晶配向劑所得的液晶顯示元件,例如可 藉由下述方法製得。 (1)在設有圖樣化的透明導電膜之基板一面上,例如藉 由輥塗覆法、旋轉器、印刷法等方法塗覆本發明之液晶配 -33- 200521207 向劑,然後,使塗覆面加熱形成塗膜。此處,基板例如可 使用平板玻璃、鹼玻璃等之玻璃;聚對酞酸乙二酯、聚對 酞酸丁二酯、聚醚酞、聚碳酸酯等之塑膠所成的透明基板。 基板一面上所設置的透明導電膜,可使用氧化錫(Sn〇2)所成 的 NESA膜(美國 PPG公司註冊商標)、氧化銦-氧化錫 (In2〇3-Sn〇2)所成ITO膜等,此等透明導電膜之圖樣化,可 使用光蝕刻法或預備光罩的方法。於液晶配向劑塗覆時, 爲使基板表面及透明導電膜與塗膜之黏合性更佳時,預先 在基板之該表面上塗覆含有官能性矽烷之化合物、含有官 φ 能性鈦之化合物等。液晶配向劑塗覆後之加熱溫度以8 0〜 300 °C較佳,更佳者爲120〜250 °C。而且,含有聚醯胺酸之 本發明液晶配向劑,於塗覆後藉由除去有機溶劑形成作爲 配向膜之塗膜,另藉由加熱進行脫水閉環,形成更爲醯亞 胺化的塗膜。所形成的塗膜之膜厚以0.001〜Ιμιη較佳,更 佳者爲0.005〜0.5μιη。 (2)使所形成的塗膜面視其所需例如耐龍、雷縈、棉等 纖維所成的布以捲附的輥朝一定方向擦拭進行摩擦處理。 φ 藉此可使塗膜上之液晶分子具有預傾角,於施加電壓時可 控制液晶分子傾倒的方向。而且,視其所需在沒有藉由摩 擦法下,可藉由偏光或無偏光之紫外線、或離子束等照射 塗膜以賦予預傾角。 此外,於本發明之垂直配向型液晶顯示元件中,施加電 壓時液晶分子之傾倒方向藉由橫電界、基板上之突起等控 制時,不一定必須進行上述摩擦等處理,可直接使用上述 塗膜作爲液晶配向膜。 -34- 200521207 (3)如上所述製作2張形成有液晶配向膜之基板,且使 各液晶配向膜之摩擦方向(或電壓施加時液晶分子之傾倒 方向)爲逆平行下’使2張基板經由縫隙(晶胞縫隙)予以對 向配置,且使2張基板之週邊使用密封劑貼合’在基板表 面及藉由密封劑區分的晶胞縫隙內注入塡充液晶,且使注 入孔密封以構成液晶晶胞。然後,在液晶晶胞之外表面、 即構成液晶晶胞之各基板的另一面上使偏光板之偏光方向 與該基板一面上形成有液晶配向膜之摩擦方向(或電壓施 加時液晶分子之傾倒方向)爲45 °下貼合,製得液晶顯示元 馨 件。 此處,密封劑例如可使用硬化劑及作爲調距板之含有氧 化鋁球的環氧樹脂等。 液晶例如有向列型液晶及層列型液晶。其中,以向列型 液晶較佳,例如可使用席夫鹼系液晶、氧化偶氮系液晶、 聯苯系液晶、苯基環己烷系液晶、酯系液晶、聯三苯系液 晶、聯苯環己烷系液晶、嘧啶型液晶、二噁烷系液晶、二 環辛烷系液晶、庫邦(譯音)系液晶。而且,在此等液晶中 φ 可添加例如氯化膽固醇、膽固醇萘酸酯、膽固醇碳酸酯等 之膽固醇型液晶或商品名「C-15」「CB-15」(梅魯谷公司 製)之市售對掌劑等。另外,可使用P-癸氧基苯亞甲基 月安基-2-甲基丁基肉桂酸酯等之強介電性液晶。 而且,貼合於液晶晶胞之外表面的偏光板,例如使聚乙 稀醇延伸配向且使與吸收碘之Η膜對稱的偏光膜以醋酸纖 糸隹素保護膜夾住的偏光板或由Η膜所成的偏光板。 【實施方式】 -35- 200521207 於下述中藉由實施例更具體說明本發明,惟本發明不受 此等實施例所限制。而且,下述實施例及比較例之液晶顯 示元件的評估方法如下所述。 (液晶顯示元件之預傾角) 以 T. J· Scheffer,et,al·,J. Appl· Phys·,vol. 19,2013 ( 1 980)記載的方法爲基準,藉由使用He-Ne雷射光之結晶回 轉法測定(此處,預傾角定義爲液晶分子之配向方向自基板 面傾斜的角度)。 合成例1 聚醯胺酸之聚合 使0.1莫耳(22.4克)2,3,5·三羧基環戊基醋酸二酐與〇·1 莫耳(40.3克)1-(2,3-二氟-4-(4-11-己基環己基)苯氧基)-2,4-二胺基苯溶解於300克N-甲基-2-吡咯烷酮中,在60°C下反 應6小時。然後,使反應混合物注入過剩的甲醇中,使反 應生成物沉澱。其次,以甲醇洗淨且在減壓、40 °C下乾燥 15小時’製得62克聚醯胺酸(以下稱爲「聚合物la」)。 醯亞胺化反應 在31.2克聚合物ia中添力□ 3 80gN -甲基-2-吡咯烷酮、7.9 克姐啶及1 0 · 2克醋酸酐,在1 2 〇 °C下醯亞胺化4小時。然 後’使反應混合液注入過剩的甲醇中,使反應生成物沉澱。 其次’以甲醇洗淨且在減壓下乾燥1 5小時,製得醯亞胺化 聚合物(以下稱爲「聚合物i b」)。 合成例2 聚醯胺酸之聚^ 除使用0.1莫耳(4 3.1克)(2,3-二氰基-4-(4-η-戊基環己基) 200521207 本基)-3,5-一胺基本甲酸酯取代〇1莫耳(4〇1克)丨_(2,3_二 氟-4-(4-η·己基環己基)苯氧基)·2,4_二胺基苯外,與合成例 1相同地,製得64克聚醯胺酸(以下稱爲「聚合物2&」)。 醯亞胺化反應 除使用32.8克聚合物2a取代31·2克聚合物“外,與合 成例1相同地,製得3 0克醯亞胺化聚合物(以下稱爲「聚 合物2b」)。 合成例3 聚醯胺酸之聚合 除使用0.1旲耳(36.8克)ι(6(4-η -己基環己基)-3 -噠阱氧 基)-2,4-一胺基苯取代〇.丨莫耳(扣^克)〗·^^-二氟_4_(4_n-B基環己基)苯氧基)_2,4-二胺基苯外,與合成例丨相同地, 製得5 7克聚醯胺酸(以下稱爲「聚合物3 a」)。 醯亞胺化反應 除使用29.6克聚合物3a取代31.2克聚合物la外,與合 成例1相同地’製得2 6克醯亞胺化聚合物(以下稱爲「聚 合物3 b」)。 合成例4 聚醯胺酸之帮合 使 〇·1 莫耳(54.6 克)1,3,3&,4,5,91:-六氫-4-(6-(4-11-戊基環 己基)-3 -噠阱氧基)_5-(四氫-2,5-二羰基-3-呋喃基)-萘并 [l,2-c] -呋喃- i,3 -二酮與〇·ι莫耳(1〇·8克)卜苯二胺溶解於 3 00克Ν-甲基-2-吡咯烷酮中,在6〇π下反應6小時。然後, 使反應混合物注入過剩的甲醇中,使反應生成物沉澱。 其次,以甲醇洗淨且在減壓、4(TC下乾燥1 5小時,製得64 -37- 200521207 克聚醯胺酸(以下稱爲「聚合物4a」)。 醯亞胺化反應 除使用32.7克聚合物4a取代31.2克聚合物la外,與合 成例1相同地,製得2 6克醯亞胺化聚合物(以下稱爲「聚 合物4b」)。 比較合成例1 聚醯胺酸之聚合 使0.1莫耳(22·4克)2,3,5-三羧基環戊基醋酸二野與〇.1 莫耳(10.8克)ρ-苯二胺溶解於3 00克Ν-甲基-2-吡咯烷酮 鲁 中,在60 °C下反應6小時。然後,使反應混合物注入過剩 的甲醇中,使反應生成物沉澱。其次,以甲醇洗淨且在減 壓、40 °C下乾燥15小時,製得27克聚醯胺酸(以下稱爲「聚 合物A a」)。 醯亞胺化反應 在16.6克聚合物Aa中添加3 80克N-甲基-2-吡咯烷酮、 7.9克吡啶及10.2克醋酸酐,在120°C下醯亞胺化反應4小 時。然後,使反應混合液注入過剩的甲醇中,使反應生成 φ 物沉澱。其次,以甲醇洗淨且在減壓下乾燥1 5小時,製得 13克醯亞胺化聚合物(以下稱爲「聚合物Ab」)。 實施例1 (1) 液晶配向劑之調製: 使合成例1所得的聚合物(1)溶解於7·丁內酯中形成固 成份濃度2.5重量%之溶液,使該溶液以孔徑1 μιη之過濾器 過濾,調製本發明之液晶配向劑。 (2) 液晶顯示元件之製作: -38- 200521207 1) 在厚度lmm之玻璃基板一面上設有由ιτ〇膜所成透 明導電膜上,使用旋轉器塗覆上述調製的本發明液晶配向 劑,藉由在180 °C下乾燥1小時形成乾燥膜厚800埃之塗膜。 2) 使形成的塗膜面使用具有捲附有耐龍製布之輥的摩 擦機器進行摩擦處理,製作液晶配向膜。其中,摩擦處理 條件爲輥之回轉數500rpm,台之移動速度icm/秒。 3) 製作2張上述形成有液晶配向膜之基板,各在基板之 外緣部上藉由篩網印刷法塗覆含有直徑1 7 μιη之氧化鋁球 的環氧樹脂系黏合劑後,使各液晶配向膜之摩擦方向互相 鲁 反平行下,使2張基板經由縫隙對向配置,且使外緣部相 接、壓熔,使黏合劑硬化。 4) 在基板表面及外緣部藉由黏合劑區分的晶胞縫隙 內,注入塡充向列型液晶「MLC-6608」(梅魯谷(譯音)公司 製),然後’使注入孔以環氧系黏合劑密封,構成液晶晶胞。 其次,在液晶晶胞之外表面上,偏光方向與液晶配向膜之 摩擦方向成45度之角度且互相直交下貼合偏光板,製作液 晶顯示元件。 g 5) 如上述製作的液晶顯示元件中液晶之預傾角爲8 9 度。而且,對液晶晶胞施加電壓及解除電壓時,沒有異常 範圍,液晶之配向性佳。 實施例2〜4 使用合成例2〜4所得的聚合物(2b)〜(4b)取代聚合物(lb) 外,與實施例1相同地製作液晶顯示元件。評估所製作的 液晶晶胞中液晶之配向性及預傾角。結果如表1所示。 實施例5 -39- 200521207 使用合成例4所得的聚合物(4 a)取代聚合物(lb)外,與實 施例1相同地製作液晶顯示元件。評估所製作的液晶晶胞 中液晶之配向性及預傾角。結果如表1所示。ο -ί (25) ο < Synthesis of polyamines > The ratio of tetracarboxylic dianhydride to diamine used in the synthesis of polyamino acids is four for one equivalent of the amine group of diamine. The acid anhydride group of the carboxylic dianhydride is preferably 0.2 to 2 equivalents, and more preferably 0.3 to 1.2 equivalents. The synthesis reaction of polyamic acid is performed in an organic solvent, preferably at a temperature of -20 to 150 t, and more preferably at a temperature of 0 to 100 ° C. Here, the organic solvent is not particularly limited as long as it can dissolve and synthesize polyamidonic acid. For example, -28- 200521207 1-methyl-2-pyrrolidone, N, Nc methylacetamide, ν, N- Aprotic polar solvents such as dimethylformamide, dimethylphthalide, butyrolactone, tetramethylurea, hexamethylphosphorylamide, etc .; m_cresol, xylenol, phenol, halogenated A phenol-based solvent such as phenol. The amount (α) of the organic solvent is preferably 0.1 to 30% by weight based on the total amount (β) of the tetracarboxylic dianhydride and the diamine compound, and the total amount of the reaction solution (α + β). In addition, the above-mentioned organic solvents may be used in the range of the polyamines which do not precipitate out, such as alcohols, ketones, esters, ethers, halogenated hydrocarbons, hydrocarbons, etc. . Specific examples of the lean solvent include methanol, ethanol, isopropyl alcohol, cyclohexanol, 4-hydroxy-4-methyl-2-pentanone, ethylene glycol, propylene glycol, 1,4-butanediol, and triethylene glycol. Alcohol, ethylene glycol monomethyl ether, ethyl lactate, butyl lactate, acetone, methyl ethyl ketone, methyl isobutyl ketone, cyclohexanone, methyl acetate, ethyl acetate, butyl acetate, methyl methoxide Propionate, ethyl ethoxy propionate, diethyl oxalate, diethyl propionate, diethyl ether, ethylene glycol methyl ether, ethylene glycol ether, ethylene glycol-η-propyl ether, ethylene glycol Small alcohol propyl ether, ethylene glycol-η-butyl ether, ethylene glycol dimethyl ether, ethylene glycol ether acetate, diethylene glycol dimethyl ether, diethylene glycol diethyl ether, diethylene glycol monomethyl ether Ether, diethylene glycol monoethyl ether, diethylene glycol monomethyl ether acetate, diethylene glycol monoethyl ether acetate, tetrahydrofuran, dichloromethane, 1,2-dichloroethane, 1,4- Dichlorobutane, trichloroethane, chlorobenzene, 0-dichlorobenzene, hexane, heptane, octane, benzene, toluene, xylene and the like. As described above, a reaction solution prepared by dissolving polyamic acid was prepared. Then, the reaction solution was poured into a large amount of a lean solvent to obtain a precipitate, and the precipitate was dried under reduced pressure to obtain a polyamic acid. In addition, by dissolving the polyamic acid in an organic solvent again, and performing the process of -29-200521207 for precipitation of one or more lean solvents, the polyamino acid can be purified. < Synthesis of fluorene imidized polymer > The fluorene imidized polymer constituting the liquid crystal alignment agent of the present invention can be synthesized by dehydrating and closing the polyamic acid. The dehydration ring closure of the polyamic acid can be achieved by heating the polyamic acid, or (II) dissolving the polyamic acid in an organic solvent, and adding a dehydrating agent and a dehydration ring-closing catalyst to the solution, depending on its location. Need to be heated. In addition, the fluorene imidized polymer used in the present invention may also include a partially dehydrated ring-closed fluorinated imidization ratio (expressed as a percentage of the repeat units formed by the fluorene imide ring in all the repeat units in the polymer ) Small φ is less than 100% of fluorinated imidized polymer. The reaction temperature of the method for heating the polyamic acid of the above (I) is 50 ~ 200 ° (: better, more preferably 60 ~ 170 ° (:. The reaction temperature is less than 50 ° (: Fully proceeded, and the molecular weight of the fluorene imidized polymer (B) obtained when the reaction temperature was higher than 200 ° C. In addition, in the method of adding a dehydrating agent and a dehydration ring-closing catalyst to the polyamic acid solution of (II), For example, acetic anhydride, propionic anhydride, trifluoric acetic anhydride, and the like can be used as the dehydrating agent. The amount of the dehydrating agent depends on the desired fluorination rate φ, and is 1 unit of polyamine repeating unit. 0.01 to 20 moles is preferred. In addition, for dehydration ring-closing catalysts, for example, tertiary amines such as pyridine, trimethylpyridine, dimethylpyridine, and triethylamine can be used. However, they are not limited to these. The amount of catalyst used is preferably from 0.0 1 to 10 moles for the dehydrating agent used for 1 mole. The imidization rate is higher as the above-mentioned dehydrating agent and dehydration ring-closing agent are used more. Organic solvents used in dehydration ring-closing reactions, such as those exemplified by users of polyamine synthesis Organic solvent. Then, the reaction temperature of the dehydration ring-closing reaction is 0 to 18 (TC is preferred, and more preferably 10 to -30-200521207 · 150 ° C. In addition, the reaction solution thus obtained is carried out by The same operation as the method for purifying polyamic acid can purify fluorinated polymers. ≪ Terminal modified polymers > Polyfluorinated acids and fluorinated polymers can also be terminals with adjusted molecular weight. Modified type. By using the terminal modified type polymer, the coating characteristics of the liquid crystal alignment agent can be improved without impairing the effect of the present invention. The terminal modified type can be used in the synthesis of polyamic acid by The reaction system is synthesized by adding an acid anhydride, a monoamine compound, a monoisocyanate compound, etc. Here, the acid anhydride is, for example, maleic anhydride, phthalic anhydride, itaconic anhydride, η-decylsuccinic anhydride, η-dodecylsuccinic anhydride. Η-tetradecyl succinic anhydride, η-hexadecyl succinic anhydride, etc. Also, monoamine compounds such as aniline, cyclohexylamine, η-butylamine, η-pentylamine, η-hexylamine, η -Heptylamine, η-octylamine, η-nonylamine, η-decylamine, η-deca Amine, η-dodecylamine, η-tridecylamine, η-tetradecylamine, η-pentadecylamine, η-hexadecylamine, η-heptadecylamine, η-octadecylamine, η-icosamine, etc. In addition, monoisocyanate compounds such as phenyl isocyanate, naphthyl isocyanate, etc. < Liquid crystal alignment agent > The liquid crystal alignment agent of the present invention is a polymer which dissolves a polymer having a specific side chain in an organic solvent, and is usually a poly The fluorinated acid and / or the fluorinated imidized polymer are composed. The temperature when preparing the liquid crystal alignment agent of the present invention is preferably 0 to 200 ° C, and more preferably 20 to 60 ° C. The composition of the liquid crystal alignment agent of the present invention The organic solvent is, for example, a solvent exemplified by a user of a synthetic reaction of polyamic acid. Further, a poor solvent exemplified by a user used in the synthetic reaction of a polyamic acid may be appropriately selected. Among these, 1-methyl-2-pyrrolidone and a solvent having a surface tension of 32 dyn / cm or less are better than -31-200521207. Solvents with a surface tension of 32 dyn / cm or less, such as 4-hydroxy-4-methyl-2-heptanone, ethylene glycol monomethyl ether, butyl lactate, butyl acetate, methyl methoxypropionate, ethyl acetate Ethoxypropionate, ethylene glycol methyl ether, ethylene glycol ether, ethylene glycol-η-propyl ether, ethylene glycol-i-propyl ether, ethylene glycol-η-butyl ether, ethylene glycol di Methyl ether, ethylene glycol ether acetate, diethylene glycol dimethyl ether, diethylene glycol diethyl ether, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, diethylene glycol monomethyl ether acetate Esters, diethylene glycol monoethyl ether acetate, and the like. The ratio of 1-methyl-2-pyrrolidine to a solvent having a surface tension of 32 dyn / cm or less, with 1-methyl-2-pyrrolidone being 20 to 60% by weight and a solvent having a surface tension of 32 dyn or less is 80 to 40 weight % Is better. When the ratio is outside the range, sufficient printability cannot be obtained because polymer precipitation occurs and the horizontality is insufficient. The solid content concentration of the liquid crystal alignment agent of the present invention can be selected in consideration of viscosity, volatility, etc., and is preferably 1 to 10% by weight. In other words, the liquid crystal alignment agent of the present invention is coated on the substrate surface to form a liquid crystal alignment film coating film, but when the solid content concentration is less than 1% by weight, the film thickness of the coating film is too small to make a good liquid crystal alignment film, and the solid content concentration is greater than At 10% by weight, the film thickness of the coating film is too large to make a good liquid crystal alignment film, and the viscosity of the liquid crystal alignment agent increases, resulting in poor coating characteristics. The liquid crystal alignment agent of the present invention includes a functional silane-containing compound and an epoxy compound within the range of physical properties that do not damage the objective, and can improve the adhesion to the substrate surface. The functional silane-containing compound such as 3-aminopropyltrimethoxysilane, 3-aminopropyltriethoxysilane, 2-aminopropyltrimethoxysilane, 2-aminopropyltriethoxy Silyl, N_ (2-aminoethyl) -3-aminopropyltrimethoxysilane, N- (2-aminoethyl) -3-aminopropyl200521207 methyldimethoxysilane, 3 -ureidopropyltrimethoxysilane, 3 -ureidopropyltriethoxysilane, N -ethoxycarbonyl-3 -aminopropyltrimethoxysilane, N -ethoxymine -3-Aminopropyltriethoxy Mortar, N-triethoxysilylpropyltriethylenetriamine, N · trimethoxysilylpropyltriethylenetriamine, 10-trimethoxy Silyl-1,4,7-triazadecane, 10-triethoxysilyl-1,4,7-triazadecane, 9-trimethoxysilyl-3,6-di Azanonyl acetate, 9-triethoxysilyl-3,6-diazenonyl acetate, N-benzyl-3-aminopropyltrimethoxysilane, N-benzyl 3-aminoaminotriethoxysilane, N-phenyl-3-aminopropyltrimethoxysilane, N-phenyl-3-φaminopropyltriethoxysilane, N- double Ethylene oxide) -3 - aminopropyl trimethoxy hospital sand, N - bis (ethylene Institute) -3 - aminopropyl triethoxy sand homes. Examples of the epoxy-containing compound include ethylene glycol diglycidyl ether, polyethylene glycol diglycidyl ether, propylene glycol diglycidyl ether, tripropylene glycol diglycidyl ether, polypropylene glycol diglycidyl ether, Neopentyl alcohol diglycidyl ether; 1,6-hexanediol diglycidyl ether, glycerol diglycidyl ether, 2,2-dibromo neopentyl alcohol diglycidyl ether, 1, 3,5,6 -tetraglycidyl-2,4-hexanediol, N, N, N ', N' · tetraglycidyl-m-diphenyldimethylamine, 1,3-bis ( N, N-Diglycidylaminomethyl) cyclohexane, φ N, N, N ', N'-Tetraglycidyl-4,4'-diaminodiphenylmethane, 3- (N-allyl-N-glycidyl) aminopropyltrimethoxysilane, 3- (N, N-glycidyl) aminopropyltrimethoxysilane, and the like. < Liquid crystal display element > The liquid crystal display element obtained by using the liquid crystal alignment agent of the present invention can be produced, for example, by the following method. (1) On one side of a substrate provided with a patterned transparent conductive film, the liquid crystal compound of the present invention is applied by, for example, a roll coating method, a spinner, or a printing method, and the coating agent is then applied. The cover is heated to form a coating film. Here, the substrate may be, for example, a glass such as flat glass or alkali glass; a transparent substrate made of plastic such as polyethylene terephthalate, polybutylene terephthalate, polyether phthalate, polycarbonate, or the like. The transparent conductive film provided on one side of the substrate can be a NESA film (registered trademark of PPG, USA) made of tin oxide (SnO2), and an ITO film made of indium oxide-tin oxide (In2〇3-Sn〇2) For patterning of these transparent conductive films, a photolithography method or a method of preparing a photomask can be used. When the liquid crystal alignment agent is applied, in order to improve the adhesion between the substrate surface and the transparent conductive film and the coating film, the surface of the substrate is coated with a compound containing a functional silane and a compound containing a functional titanium in advance. . The heating temperature after the liquid crystal alignment agent is applied is preferably 80 to 300 ° C, and more preferably 120 to 250 ° C. In addition, the liquid crystal alignment agent of the present invention containing polyamic acid forms a coating film as an alignment film by removing an organic solvent after coating, and further dehydrates and closes the ring by heating to form a more imidized coating film. The film thickness of the formed coating film is preferably 0.001 to 1 μm, and more preferably 0.005 to 0.5 μm. (2) The formed coating film surface is rubbed in a certain direction with a roll wrapped with a cloth made of fibers such as nylon, thunder, cotton, etc., as required, for rubbing treatment. φ can make the liquid crystal molecules on the coating film have a pretilt angle, and can control the direction in which the liquid crystal molecules fall when a voltage is applied. In addition, if necessary, the coating film can be irradiated with polarized or unpolarized ultraviolet rays, or ion beams to impart a pretilt angle without rubbing. In addition, in the vertical alignment type liquid crystal display element of the present invention, when the tilting direction of the liquid crystal molecules when a voltage is applied is controlled by the transverse electrical boundary, the protrusion on the substrate, etc., the above-mentioned friction and other treatments are not necessarily required, and the above-mentioned coating film can be directly used. As a liquid crystal alignment film. -34- 200521207 (3) Make two substrates with the liquid crystal alignment film formed as described above, and make the rubbing direction of each liquid crystal alignment film (or the direction in which the liquid crystal molecules are tilted when a voltage is applied) is anti-parallel. They are arranged opposite to each other through a gap (cell gap), and the two substrates are bonded together with a sealant on the substrate surface. The liquid crystal is injected into the cell surface and the cell gap separated by the sealant, and the injection hole is sealed. Forms a liquid crystal cell. Then, on the outer surface of the liquid crystal cell, that is, on the other surface of each substrate constituting the liquid crystal cell, the direction of polarization of the polarizing plate and the rubbing direction of the liquid crystal alignment film formed on one surface of the substrate (or the liquid crystal molecules are dumped when a voltage is applied (Direction) is bonded at 45 ° to obtain a liquid crystal display element. Here, as the sealant, for example, a hardener and an epoxy resin containing aluminum oxide balls as a pitch control plate can be used. The liquid crystal includes, for example, a nematic liquid crystal and a smectic liquid crystal. Among them, nematic liquid crystals are preferred. For example, Schiff base liquid crystals, azo oxide liquid crystals, biphenyl liquid crystals, phenylcyclohexane liquid crystals, ester liquid crystals, bitriphenyl liquid crystals, and biphenyl can be used. Cyclohexane-based liquid crystals, pyrimidine-based liquid crystals, dioxane-based liquid crystals, dicyclooctane-based liquid crystals, and Cooper (transliterated) liquid crystals. In addition, to these liquid crystals, φ can be added to cholesterol-type liquid crystals such as chlorinated cholesterol, cholesterol naphthalate, and cholesterol carbonate, or the market names of "C-15" and "CB-15" (manufactured by Meru Valley). Sale of palm agent. In addition, a strong dielectric liquid crystal such as P-decoxybenzylidene monthyl-2-methylbutylcinnamate can be used. In addition, a polarizing plate attached to the outer surface of the liquid crystal cell, for example, a polarizing plate in which the polarizing film is stretched and aligned with the iodine-absorbing ytterbium film is sandwiched by a cellulose acetate protective film or a polarizing plate A polarizing plate made of diaphragm. [Embodiment] -35- 200521207 In the following, the present invention will be described more specifically by way of examples, but the present invention is not limited by these examples. The evaluation methods of the liquid crystal display elements of the following examples and comparative examples are as follows. (Pre-tilt angle of the liquid crystal display element) Based on the method described in T. J. Scheffer, et, al., J. Appl. Phys., Vol. 19, 2013 (1 980), He-Ne laser light was used It is measured by the crystal rotation method (here, the pretilt angle is defined as the angle at which the alignment direction of the liquid crystal molecules is inclined from the substrate surface). Synthesis Example 1 Polymerization of polyamic acid caused 0.1 mol (22.4 g) of 2,3,5 · tricarboxycyclopentylacetic dianhydride and 0.1 mol (40.3 g) of 1- (2,3-difluoro -4- (4-11-hexylcyclohexyl) phenoxy) -2,4-diaminobenzene was dissolved in 300 g of N-methyl-2-pyrrolidone and reacted at 60 ° C for 6 hours. Then, the reaction mixture was poured into an excess of methanol to precipitate a reaction product. Next, it was washed with methanol and dried under reduced pressure at 40 ° C for 15 hours' to obtain 62 g of polyamidic acid (hereinafter referred to as "polymer la").醯 Imidization reaction added power to 31.2 grams of polymer ia □ 3 80 g of N-methyl-2-pyrrolidone, 7.9 grams of elderidine and 10 · 2 grams of acetic anhydride, 醯 imidization at 120 ° C 4 hour. Then, the reaction mixture is poured into excess methanol to precipitate the reaction product. Next, it was washed with methanol and dried under reduced pressure for 15 hours to obtain a perylene imidized polymer (hereinafter referred to as "polymer i b"). Synthesis Example 2 Polymerization of Polyamino Acid Except 0.1 mol (4 3.1 g) (2,3-dicyano-4- (4-η-pentylcyclohexyl) 200521207 base) -3,5- Monoamine basic formate substituted with 0.01 mole (40.1 g) 丨 (2,3-difluoro-4- (4-η · hexylcyclohexyl) phenoxy) · 2,4-diamine Except for benzene, in the same manner as in Synthesis Example 1, 64 g of polyamic acid (hereinafter referred to as "Polymer 2 &") was obtained. The fluorene imidization reaction was carried out in the same manner as in Synthesis Example 1 except that 32.8 g of the polymer 2a was used instead of 31.2 g of the polymer. . Synthesis Example 3 Polymerization of polyamidoacid except that 0.1 旲 (36.8 g) (6 (4-η-hexylcyclohexyl) -3 -pyridyloxy) -2,4-monoaminobenzene was substituted.丨 Moore (deduction ^ g) 〖^^-difluoro_4_ (4_n-B-cyclohexyl) phenoxy) _2,4-diamino benzene was prepared in the same manner as in Synthesis Example 丨 5 7 G of polyamic acid (hereinafter referred to as "Polymer 3 a"). Perylene imidization reaction In the same manner as in Synthesis Example 1 except that 29.6 g of polymer 3a was used in place of 31.2 g of polymer la, 26 g of perylene imidized polymer (hereinafter referred to as "polymer 3b") was prepared. Synthetic Example 4 Polyacrylamide's conjugate makes 0.1 mol (54.6 g) 1,3,3 &, 4,5,91: -hexahydro-4- (6- (4-11-pentyl ring) Hexyl) -3 -pyridyloxy) _5- (tetrahydro-2,5-dicarbonyl-3-furanyl) -naphtho [l, 2-c] -furan-i, 3-dione with 〇 · Mol (10.8 g) of phenylenediamine was dissolved in 300 g of N-methyl-2-pyrrolidone and reacted at 60π for 6 hours. Then, the reaction mixture was poured into excess methanol to precipitate a reaction product. Next, it was washed with methanol and dried under reduced pressure at 4 ° C for 15 hours to obtain 64-37-200521207 g of polyamidic acid (hereinafter referred to as "polymer 4a"). 32.7 g of polymer 4a was substituted for 31.2 g of polymer la, and 26 g of fluorenimidized polymer (hereinafter referred to as "polymer 4b") were obtained in the same manner as in Synthesis Example 1. Comparative Synthesis Example 1 Polyamic acid Polymerization dissolves 0.1 mol (22.4 g) of 2,3,5-tricarboxycyclopentyl acetate dino and 0.1 mol (10.8 g) of p-phenylenediamine in 300 g of N-methyl In 2-pyrrolidinone, react at 60 ° C for 6 hours. Then, pour the reaction mixture into excess methanol to precipitate the reaction product. Next, wash with methanol and dry under reduced pressure at 40 ° C for 15 Hours, 27 grams of polyamidoic acid (hereinafter referred to as "Polymer A a") was prepared. 醯 imidization reaction To 16.6 grams of polymer Aa was added 3 80 grams of N-methyl-2-pyrrolidone and 7.9 grams of pyridine And 10.2 g of acetic anhydride, and then reacted with imidization at 120 ° C for 4 hours. Then, the reaction mixture was poured into excess methanol to precipitate the reaction product φ. Second It was washed with methanol and dried under reduced pressure for 15 hours to obtain 13 g of fluorinated imidized polymer (hereinafter referred to as "polymer Ab"). Example 1 (1) Preparation of liquid crystal alignment agent: Synthesis Example The polymer (1) obtained in 1 was dissolved in 7.butyrolactone to form a 2.5% by weight solid content solution, and the solution was filtered through a filter having a pore size of 1 μm to prepare the liquid crystal alignment agent of the present invention. (2) Liquid crystal Production of display elements: -38- 200521207 1) A transparent conductive film made of ιτ〇 film is provided on one side of a glass substrate with a thickness of 1 mm, and the liquid crystal alignment agent of the present invention prepared as described above is coated with a spinner. Dry for 1 hour at ° C to form a coating film with a dry film thickness of 800 angstroms. 2) The formed coating film surface is subjected to a rubbing treatment using a rubbing machine having a roll wound with a dragon resistant cloth to produce a liquid crystal alignment film. Among them, the friction treatment conditions are 500 rpm of the rotation speed of the roller and icm / second of the moving speed of the table. 3) Two substrates having the above-mentioned liquid crystal alignment film formed, each of which was coated with an epoxy-based adhesive containing alumina balls with a diameter of 17 μm by screen printing on the outer edge of the substrate, and each The rubbing directions of the liquid crystal alignment film are anti-parallel to each other, so that the two substrates are arranged to oppose each other through the gap, and the outer edges are connected and pressure-melted to harden the adhesive. 4) Inject the pseudo-nematic liquid crystal "MLC-6608" (made by Meru Valley, Inc.) into the cell gap between the substrate surface and the outer edge separated by the adhesive, and then 'ring the injection hole An oxygen-based adhesive is sealed to form a liquid crystal cell. Next, on the outer surface of the liquid crystal cell, the polarizing direction and the rubbing direction of the liquid crystal alignment film are at an angle of 45 degrees, and the polarizing plates are bonded to each other at right angles to produce a liquid crystal display element. g 5) The pretilt angle of the liquid crystal in the liquid crystal display element produced as described above is 89 degrees. In addition, when a voltage is applied to and released from the liquid crystal cell, there is no abnormal range, and the alignment of the liquid crystal is good. Examples 2 to 4 A liquid crystal display device was produced in the same manner as in Example 1 except that the polymers (2b) to (4b) obtained in Synthesis Examples 2 to 4 were used instead of the polymer (lb). The alignment and pretilt angle of the liquid crystal in the produced liquid crystal cell were evaluated. The results are shown in Table 1. Example 5 -39- 200521207 A liquid crystal display device was produced in the same manner as in Example 1 except that the polymer (4 a) obtained in Synthesis Example 4 was used instead of the polymer (lb). The alignment and pretilt angle of the liquid crystal in the produced liquid crystal cell were evaluated. The results are shown in Table 1.

-40- 200521207 表1 實施例 聚合物 預傾角(° ) 1 lb 89 2 2b 88 3 3b 87 4 4b 89 5 4 a 87 比較例 除使用比較合成例1所得的聚合物(Ab)取代聚合物(lb) φ 外,與實施例1相同地製作液晶顯示元件。製作的液晶顯 示元件中液晶之預傾角爲1度以下,沒有垂直配向。-40- 200521207 Table 1 Example polymer pretilt angle (°) 1 lb 89 2 2b 88 3 3b 87 4 4b 89 5 4 a 87 Comparative Example Except the polymer (Ab) substituted polymer obtained in Comparative Synthesis Example 1 ( lb) φ, a liquid crystal display element was produced in the same manner as in Example 1. The pretilt angle of the liquid crystal in the produced liquid crystal display element was 1 degree or less, and there was no vertical alignment.

-41 --41-

Claims (1)

200521207 十、申請專利範圍: 1. 一種液晶配向劑,其特徵爲在側鏈上具有至少含一種選 自於下述式(I)所示構造及下述式(Π)所示構造之聚合物’200521207 10. Scope of patent application: 1. A liquid crystal alignment agent, which is characterized by having on the side chain at least one polymer selected from the group consisting of the structure represented by the following formula (I) and the structure represented by the following formula (Π) ' (其中,A1及B1互相獨立地爲氫原子、鹵素原子或氰基 惟A1及B1中至少一個爲鹵素原子或氰基),(Wherein A1 and B1 are independently a hydrogen atom, a halogen atom or a cyano group, but at least one of A1 and B1 is a halogen atom or a cyano group), Ν—Ν • . . * · · ·.. ·. · · • . . ... 〇 Μ 2. 如申請專利範圍第1項之液晶配向劑,其中聚合物係爲 具有下述式(III)所示之基作爲側鏈之聚合物, —P-Q-R1—R2 (πι) φ (其中,Ρ爲單鍵、-〇-、-COO-或- C〇NH-,Q爲上述式(I) 所示構造或上述式(11)所示構造,R 1爲2價脂環族基,R2 爲碳數1〜22之直鏈狀烷基)。 3. 如申請專利範圍第1或2項之液晶配向劑,其中聚合物 爲在主鏈中具有聚醯胺酸構造及/或聚醯亞胺構造。 4 · 一種液晶顯示元件,其特徵爲具備由如申請專利範圍第1 至3項中任一項之液晶配向劑所形成的液晶配向膜所成。 -42- 200521207 七、指定代表圖·· (一) 本案指定代表圖為:無。 (二) 本代表圖之元件符號簡單說明: Μ 〇 j \ \\ 八、本案若有化學式時,請揭示最能顯示發明特徵的化學式:Ν—Ν •.. * · · · · · · · · · · · · · 2. OM 2. As the liquid crystal alignment agent in the scope of patent application No. 1, wherein the polymer has the following formula (III) The group shown is a polymer with a side chain, —PQ-R1—R2 (πι) φ (wherein P is a single bond, -0-, -COO-, or -CONH-, and Q is the above formula (I) The structure shown or the structure shown by the above formula (11), R 1 is a divalent alicyclic group, and R 2 is a linear alkyl group having 1 to 22 carbon atoms). 3. The liquid crystal alignment agent according to item 1 or 2 of the patent application scope, wherein the polymer has a polyamidic acid structure and / or a polyamidoimine structure in the main chain. 4. A liquid crystal display element, comprising a liquid crystal alignment film formed of a liquid crystal alignment agent according to any one of claims 1 to 3. -42- 200521207 VII. Designated representative map (1) The designated representative map in this case is: None. (2) Brief description of the component symbols of this representative figure: Μ 〇 j \ \\ 8. If there is a chemical formula in this case, please disclose the chemical formula that can best show the characteristics of the invention: (I)(I) (II)(II)
TW093130811A 2003-11-06 2004-10-12 Liquid crystal alignment agent and liquid crystal display element TWI346690B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2003376792A JP4433150B2 (en) 2003-11-06 2003-11-06 Liquid crystal aligning agent and liquid crystal display element

Publications (2)

Publication Number Publication Date
TW200521207A true TW200521207A (en) 2005-07-01
TWI346690B TWI346690B (en) 2011-08-11

Family

ID=34687727

Family Applications (1)

Application Number Title Priority Date Filing Date
TW093130811A TWI346690B (en) 2003-11-06 2004-10-12 Liquid crystal alignment agent and liquid crystal display element

Country Status (3)

Country Link
JP (1) JP4433150B2 (en)
KR (2) KR101035438B1 (en)
TW (1) TWI346690B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI427121B (en) * 2006-09-01 2014-02-21 Jnc Corp Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101184319B1 (en) * 2009-01-29 2012-09-19 제이엔씨 주식회사 Alignment agent and liquid crystalline polyimide used therein

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05127167A (en) * 1991-11-07 1993-05-25 Fuji Photo Film Co Ltd Oriented film
JP4165062B2 (en) * 2001-12-18 2008-10-15 チッソ株式会社 Compound having difluoromethyleneoxy and polymer thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI427121B (en) * 2006-09-01 2014-02-21 Jnc Corp Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element

Also Published As

Publication number Publication date
KR20110010833A (en) 2011-02-07
KR20050043686A (en) 2005-05-11
TWI346690B (en) 2011-08-11
KR101035438B1 (en) 2011-05-18
JP4433150B2 (en) 2010-03-17
KR101032520B1 (en) 2011-05-04
JP2005139288A (en) 2005-06-02

Similar Documents

Publication Publication Date Title
CN101299119B (en) Vertical alignment type liquid crystal alignment agent and liquid crystal display element
KR101481834B1 (en) Liquid crystal aligning agent and liquid crystal display device
JPH10104633A (en) Liquid crystal alignment agent
JPH09316200A (en) Liquid crystal alignment agent
CN102453486A (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
TW200832019A (en) Liguid crystal alignment agent and liquid crystal display element
KR101567605B1 (en) Liquid crystal aligning agent and liquid crystal display device
JP5071662B2 (en) Liquid crystal aligning agent and liquid crystal display element
KR101501778B1 (en) Liquid crystal aligning agent and liquid crystal display element
KR101501777B1 (en) Liquid crystal aligning agent and liquid crystal display element
TW200819510A (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
KR101536007B1 (en) Liquid crystal aligning agent and liquid crystal display element
TWI659981B (en) Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display device
KR101501779B1 (en) Liquid crystal aligning agent and liquid crystal display element
KR101502628B1 (en) Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element
KR101509768B1 (en) Vertical alignment type liquid crystal alignment agent and vertical alignment type liquid crystal display element
JP2001311080A (en) Liquid crystal alignment agent
CN101241274A (en) Liquid crystal aligning agent, liquid crystal aligning film and liquid crystal display element
JP2000336168A (en) Polyamic acid, polyimide, liquid crystal aligning agent and liquid crystal display device
KR101042059B1 (en) Liquid crystal aligning agent and liquid crystal display element
KR101520971B1 (en) Liquid crystal aligning agent and liquid crystal display device
TW200521207A (en) Liquid crystal alignment agent and liquid crystal display element
TWI660981B (en) Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element having the same
KR101520972B1 (en) Liquid crystal aligning agent and liquid crystal display device
TW200526762A (en) Liquid crystal alignment agent and liquid crystal display element

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees